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From the Sponsor 
June 3, 1998 
On behalf of Ralston Purina Company, I'd like to welcome you to the Rrst International Feline Genetic Disease Conference and thank you 
for your interest in and support of these efforts which we believe will improve the health and happiness of cats everywhere. 
Ralston Purina is proud to sponsor this event and participate with the University of Pennsylvania's School of Veterinary Medicine and Wlnn 
Feline Foundation. Purina has over 70 years of experience in improving the health of cats through nutrition research conducted at the Purina 
Pet Care Center and through collaboration with our colleagues In veterinary colleges across the country. Our long-standing commitment to 
research has provided a steady stream of new knowledge which we incorporate into all of our products. 
Ralston Purina and Wlnn Feline Foundation share a common interest in helping to continually Improve the lives of cats. Sponsoring this 
conference indicates our dedication toward that interest. The potential of what any cat ·can be' is the product of genetics, nutrition and envi­
ronment. We are particularly interested in participation with you in discovering the secrets of feline genetics, the very blueprint of a eat's bio­
logical being, so as to provide optimal feline nutrition which will lead to the best possible life for cats. 
Again, we would like to thank you for your attendance at this important conference and hope your experience will benefit you. Purina is 
pleased you are here and we look forward to a continuing partnership in improving the lives of cats. 
Purina 
® 
Ralston Purina, the leader in molecular nutritionN 
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Sincerely, 
Dr. David M. Bebiak 
Vice President a Director 
Pet Products Rao 
Ralston Purina Company 
Checkerboard Square 
St. Louis, MO 63164-0001 
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Dear Conference Participants: 
We would like to take this opportunity to welcome you to the First International Feline Genetic Disease 
Conference at the School of Veterinary Medicine, University of Pennsylvania. This is the first international con­
ference dedicated to hereditary disorders in cats and the feline gene map focusing on the future of feline 
health. Currently, over 150 genetic diseases have been reported in domestic and purebred cats and several 
additional disorders are being discovered every year. During this decade the molecular defects for nearly 10 
hereditary disorders have been identified. Based upon major advancements in molecular genetics and the 
human genome project, a first feline gene map has also recently been developed. 
We believe that this conference will provide a state-of-the-art program on the emerging field of feline 
genetics: a two-day conference for scientists and clinical investigators is followed by a one-day conference for 
cat breeders, pet owners, and feline practitioners. This format of the conference, with over 70 presentations, 
should provide new insight into feline genetics for everyone, offer novel approaches for investigators, and 
generate new collaborative studies between scientists, clinicians, and breeders. Such efforts will likely help to 
eliminate many hereditary disorders and reduce the frequency of known genetic diseases in future genera­
tions. 
The School of Veterinary Medicine at the University of Pennsylvania has a long-standing history of con­
tributing to clinical and basic genetics and is very proud to host the First International Feline Genetic Disease 
Conference. We are grateful to the Ralston Purina Company and the Winn Feline Foundation for their involve­
ment in improving the well-being of cats and for their co-sponsoring this event; this generous support is great­
ly appreciated. 
Sincerely, 
Alan M. Kelly, BVSc, MRCVS, PhD 
The Gilbert S. Kahn Dean of Veterinary Medicine 
Urs Giger, PhD, Dr.med.vet, MS 
The Charlotte Newton Shepphard Professor of Medicine and Medical Genetics 
School of Veterinary Medicine 
University of Pennsylvania 
3800 Spruce Street 
Philadelphia, PA 19104 
Feline Prsctics • Supplement 1999 
4 
5 
5 
6 
6 
6 
7 
7 
8 
8 
8 
9 
9 
9 
FIRST INTERNATIONAL FELINE GENETIC DISEASE CONFERENCE 
Scl10ol of Veterinary Medicine. University of Pennsylvania Veterinary Hospital. 3850 Spruce Street Plliladelpllia. PA 
June 25 - 28, 1998 
SCIENTIFIC PROGRAM 
Evolution of the family felidae 10 Feline cytogenetics: Karyotypes, FISH and 
Stephen O'Brien painting 
William Nash 
Lysosomal storage diseases (LSD) in cats: 
11 An overview The molecular bases of feline GMl and GM2 
Mark Haskins gangliosidoses 
Feline hereditary coagulopathies 
Henry Baker 
Marjory Brooks 11 Autosomal dominant polycystic kidney 
The feline genome project: Development of 
disease in Persian cats 
Steven DiBartolo 
the type I linkage map of the cat using feline 
11 interspecles hybrids A genetic linkage map of polymorphic 
Leslie Lyons microsatellites In the domestic cat (Felis catus) 
Niemann-Pick disease type c 
Marilyn Menotti-Raymond 
Mary A. Thrall 12 Assisted reproductive technology for 
Heritable characteristics, phenotypic 
facilitating management of feline hereditary 
disease models 
expression, and natural history of hypertrophic William Swanson 
cardiomyopathy in Maine Coon cats 
12 Mark Kittleson The heritability of susceptibility to infectious 
Identification of nine polymorphisms within 
disease In domestic cats 
Janet E. Foley 
the head region of the feline beta myosin heavy 
13 chain gene Hereditary eye diseases 
Kathryn Meurs Kristina NarjstrtJm 
Erythrocyte pyruvate kinase deficiency in cats 13 Characterization of genomic organization In 
Urs Giger feline MHC Class I and II region using feline PAC 
Feline MPS VI as a model to study pathology 
genomic library 
Naoya Yuhki 
and evaluate efficacy of therapy for 
14 Maroteaux-Lamy syndrome patients Feline a-mannosidosis: From molecular 
John Hopwood genetics to therapy 
Construction and analysis of bacterial and Pl 
Steven Walkley 
artificial chromosome libraries from the 14 Development strategies for DNA-based tests for 
domestic cat cat parentage verification 
Thomas Beck Ann Bowling 
Hemoglobin polymorphism 15 Feline amyloidosis 
Barbara Kahn Erik Gruys 
Chylomlcronemla & Inherited lipoprotein 15 Medical genetics and the domestic cat - A 
lipase deficiency In domestic cats potpurry of thoughts, experiences, and some 
Boyd Jones genetic disorders encountered during 30 years 
Dystrophln-deflcient hypertrophic feline 
in the field 
Donald Patterson 
muscular dystrophy In the cat 
Frederic Gaschen 
10 Glycogen storage disease type IV in 
Norwegian Forest cats: Molecular detection 
of carriers 
John Fyfe 
Feline Practice • Supplement 1 999 
T
e classification of the species of the family Felidae has been contro­
ersial for 200 years. Classic taxonomies range from clumping cats 
nto two maJor lineages to liberals splitting cats into as many as twen· 
ty lineages. Currently, at least four different classification schemes are 
common for cats. Our laboratories have employed high and low G·banded 
karyotypes, albumin immunological distances, retroviral sequences, 
DNNDNA hybridizations, isozymes, 2-D protein electrophoresis, minisatel· 
lites and both mitochondrial RFLPs and sequences to tackle the ancient rela· 
tionships of the saber-toothed tiger to present divisions of sub-species. Early 
Evolution of the Family Felidae 
Stephen J. O'Brien', Glen E. Collier', William G. Nash', WiHiam S. Modi', 
Raoul E. Benveniste', Dianne N. Janczewski', JiH Pacon-Slattery', Warren 
E. Johnson', Peter A. Dratch', Eduardo Eizirik', Leslie A. Lyons' 
'Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD; 
'H & W Cytogenetics, Lovettsville, VA 
wor1< with albumin immunological distances separated cats into three major lineages; the ocelot lineage of South American cats split near· 
ly 12 million years ago, followed by the domestic cat branch of 8 • 10 m.y.a. and most recently the big cat lineage of Panthera, about 4· 
6 m.y.a. This most recent split also showed smaller branches, including a recent split between modem great cats and lynxes only 2 m.y.a. 
Low resolution G-banded karyotypes supported this early worK. Rfteen of the 19 chromosome pairs are invariant in all cat species. Most 
of the karyotypic variation occurs in the early phase of the pantherine lineage. Retroviruses, RD-114 and FeLV, liquid hybridizations and 
isozyme data recapitulated these results and different techniques have been investigated to more finely resolve the major feline lineages. 
Mitochondrial RFLP studies have been able to refine some of the relationships within the major lineages; grouping lions and leopards and 
tigers and snow leopards within Panthera, splitting the ocelot lineage into three sister taxa, and dividing the domestic cat lineage into sev· 
eral smaller lineages. Sequence analyses of mitochondrial DNA have further resolved the cats into eight major clusters, including; the 
ocelot lineage, the domestic cat lineage, the Panthera genus, the puma group, the Lynx genus, the Asian leopard cat group, the caracal 
group and the bay cat group. Our lab will continue to employ these standard and more novel techniques to clarify the relationships of our 
feline friends and to provide insight to a broad range of applications, including the study of endogenous retroviruses, gene evolution, pop­
ulation bottlenecks, infectious disease transmission, and species conservation. 
LJysosomes and their ·housekeeping" enzymes function in degrading large complex 
ubstrates which have been taken into a cell by endocytosis. In normal cells, lyso­
somal enzymes are translocated into the lumen of the endoplasmic reticulum 
here high mannose oligosaccharides are added. Further post-translational modi­
fication results when enzymes add a mannose-6-phosphate (Man-6-P) moiety, recognized 
by membrane glycoprotein receptors, permitting transfer of the enzymes to lysosomes. A 
proportion of the Man-6-P-enzymes may also leave the cell via secretory granules. 
secreted enzyme can ultimately reach the lysosome because Man-6·P receptors are pre­
sent in the plasma membrane of many cells. 
Degradation of most substrates occurs by the activity of a series of hydrolases in a 
Lysosomal Storage Diseases 
in Cats: An Overview 
Mark E. Haskins VMD, PhD 
School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia, PA 
stepwise fashion, each step requiring the action of the previous enzyme to modify the substrate, thereby permitting catabolism to proceed 
to the next enzyme step in the pathway. If one step in the process fails, further degradation ceases. The lysosomal storage diseases are a 
group of genetic disorders of this cellular catabolism. 
Most lysosomal storage diseases are inherited as autosomal recessive traits and result from mutations in the coding sequence of one 
of the acid hydrolases located in lysosomes. The reduction in enzyme actMty results in the accumulation within lysosomes of the suo­
strate of that enzyme, hence the name lysosomal storage disease. The first definitive discovery of a lysosomal storage disease in a feline 
was �1 gangliosidosis in a Siamese cat by Baker et al. in 1971. Additional diseases have been described: globoid cell leukodystrophy, 
GM2 gangliosidosis, glycogen storage disease II, alpha·mannosidosis, and mucopolysaccharidosis I, VI, and VII. Mucolipidosis II is an excep­
tion to the usual pathogenesis of a lysosomal storage disease. This disorder results from a failure in a post-translational phosphotrans· 
ferase, producing many lysosomal enzymes which lack the Man-6-P signal responsible for efficiently directing the hydrolases to lysosomes. 
Thus, little of many enzymes reach lysosomes, and large amounts are secreted into the extracellular fluid and can be detected in the serum. 
As substrates accumulate, the lysosomes swell and occupy more and more of the cytoplasm. This increase in the number and size of 
lysosomes may obscure the other cellular organelles, and may deform the nuclear outline. As the process continues, the affected cells 
swell leading to organomegaly. Wrth the exception of the central nervous system, and cartilage and bone, the pathophysiology of these 
disorders is related to the increase in the cell, tissue, or organ size. The predominant clinical signs are related to the CNS, skeleton, eye, 
cardiovascular system, and organomegaly. A final diagnosis for lysosomal storage diseases requires the demonstration of a particular 
enzyme deficiency. Enzyme assays can usually be performed on serum, white blood cells, cultured fibroblasts, or liver. Generally, there is 
a profound deficiency in activity of the enzyme. Many of these disorders in cats have been described at the molecular level, including the 
gangliosidoses, alpha-mannosidosis, and mucopolysaccharidoses making the detection of heterozygotes more straightforward than by 
enzyme actMty determination. 
Therapy: The secretion of lysosomal enzymes by cells, and uptake via the plasma membrane Man-6-P receptor system, forms the basis 
for current approaches to therapy. Providing normal enzyme to abnormal cells pennits the enzyme to be taken up by the plasma mem­
brane receptor, resulting in delivery of the normal enzyme to lysosomes where it can catabolize stored substrate. Current approaches to 
deliver normal enzymes include 1) parenteral injection of purified recombinant normal enzyme, 2) heterologous bone marrow transplan· 
tation, which provides a continuous source of normal enzymes from bone marrow-derived cells, and 3) gene therapy whereby a viral vee· 
tor is used to transfer a copy of the normal enzyme eDNA to a patient's own cells, which then act as a source of normal enzyme. 
Supported by NIH grants RR 02512, DK 25795, EY 07705, and DK 54481. 
Haskins, M. E. and Giger, U. (1997) Lysosomal Storage Diseases in Oinical Biochemistry of Domestic Animals, 5th edition, Kaneko, JJ., 
Harvey, J.W., and Bruss, M.L. (eds.), Academic Press, New York, pp 741·761. 
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I 
Feline Hereditary Coagu lopathies 
Marjory B. Brooks Gagulation disorders in cats are caused by deficiency or dysfunction of clot· ng factors. Clotting factors are plasma proteins that interact to generate fib­n clots at sites of blood vessel injury. Heritable coagulation disorders are aused by mutations in the various genes coding for spectllc clotting fac: 
tors. New or spontaneous mutations can arise in any purebred or DSH/DLH cat. 
Once a mutation occurs, detects are most often propagated when asymptomatic 
carriers are bred. 
Comparative Coagulation Section, Diagnostic Laboratory, Come// 
University, Ithaca, NY 
I 
I. Clinical Signs of Coagulopathies 
The most common signs of dotting factor deficiencies include spontaneous bleeding into joints, muscles or body cavities (chest, 
abdomen), and development of hematoma (swelling filled with blood) beneath the skin. Prolonged or excessive bleeding occurs from sites 
of surgery or trauma, and may occur from the gums in association with tooth eruption. Oinical severity of the bleeding tendency varies 
for deficiencies of different factors, and may also vary between defects appearing in unrelated indMduals. 
II. Diagnosis of Coagulopathies 
Coagulation screening tests (abbreviated a PIT, PT, TIT ) and fibrinogen assays detect functional defects in groups of factors within the 
coagulation cascade. These assays are useful for initial evaluation of cats suspected of having Inherited or acquired factor deficiencies. It 
is important that testing laboratories specifically validate their assays for feline patients. The results of coagulation screening tests provide 
the basis for determining whether and which individual factor assays should be performed. specific factor assays establish definitive diag· 
nosis of an inherited factor deficiency and offer predictions of clinical severity • 
Ill. Specific Heritable Coagulopathies 
The most common inherited feline coagulation disorders include dysflbrinogenemia (factor I deficiency), hemophilia (factors VIII' or IX 
deficiency) and factor XII deficiency. 
Dysflbrinogenemia is a deficiency or dysfunction of fibrinogen, seen most frequently in DSH cats. It is an autosomal trait; both males 
and females are affected. Spontaneous bleeding episodes are uncommon, but prolonged bleeding is typically seen from venipuncture and 
after surgery or trauma. 
Hemophilia is the most common severe factor deficiency in cats. There are 2 forms; hemophilia A caused by factor VIII deficiency and 
hemophilia B caused by factor IX deficiency. Both forms are X·linked, recessive traits. Hemophilic males Inherit an abnormal gene from 
their dams and express a bleeding tendency. Female carriers have one normal and one abnormal gene, and are clinically normal. 
Hemophilia has been identified in DSH/DLH, British shorthair, Havana Brown, Himalayan, Persian, and Siamese cats. 
Factor XII deficiency is common in DSH/DLH cats. It is an autosomal trait, both males and females are affected. This defect is unusu· 
al because deficiency of factor XII does not cause a bleeding tendency, although coagulation screening tests are prolonged. In human 
beings, factor XII deficiency may be associated with thrombotic tendencies. 
The Feline Genome Project: Agenetic recombination map is being developed for the domestic cat. Both coding genes, Type I markers, and mlaosatellltes, Type II markers, are being mapped in a feline interspecies hybrid backcross between the domestic cat, Felis catus, and the Asian leopard cat, Prionailurus bengalen· 
sis. The feline hybrids were produced by both natural and assisted reproduction 
techniques. There are over 70 backcross cats in the hybrid cross, which will ensure 
a genetic map that can determine recombination distances between 4·28 eM with 
LOD scores >3.0 for fully informative markers. over 350 1YJ>e I markers and 250 
Type II markers have been developed for the mapping project. The Type I markers 
are represented by the comparative anchor tagged sequences, CATS, which are 
Development of the Type I Linkage 
Map of the Cat Using Feline 
lnterspecies Hybrids 
Letlle A. Lyons, Stephen J. O'Brien 
Laboratory of Genomic Diversity, Frederick cancer Research and 
Development Center, National Cancer Institute, Frederick, MD 
primer sets that amplify lntronic regions of coding genes. The CATS were selected 
by combining information from the human physical and murine linkage maps, ensuring adequate genome coverage and even spacing. 
The parental cats of the interspecific hybrid diverged approximately 5·8 million years ago, thus a majority of the Type I markers are fully 
informative in this reference family. The integration of the Type I and Type II markers on the same pedigree will facilitate gene mapping 
efforts and population genetic studies in the domestic cat and establish the cat as a strong representative for the carnivora in genomic 
evolution studies. We will present the Type I linkage data for markers found on five different human chromosomes. This data will be com­
bined with the feline chromosome painting results and compared to published data from other species. The feline genetic map will fadl· 
itate the identification of disease genes such as; polycystic kidney disease, progressive retinal atrophies, spasticity, and congenital head 
defects, and phenotypic homologs, such as dwarfism, coat colors and fur types, found in other mammals. 
I 
Niemann-Pick Disease Type C 
Mary A. Thrall', Kyra L Royals', Diane E. Brown', Mary 0. Smith', Thomas W. 
Mitchell', Philip A. Marcti, Eugene D. CBJStea3, Steven U. Walkley', David A. Wenger 
'Department of Pathology, College of Veterinary Medicine and Biomedical Sciences, 
Colorado State University. Fort Collins, CO 80523; 'Department of Neuroscience, 
Albert Einstein Collage of Medicine, Bronx, NY 10461;'Saccomanno Research 
Institute, Saint Mary's Hospital and Medical Center, Grand Junction, CO 81501; 
'JeffefS(}Il Medical College, Thomas Jefferson University, Philadelphia, PA 
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N iemann·Pick disease includes two metabolically distinct disorders, both of which have been reported in cats. Niemann·Pick types A and B are acid sphingomyelinase deficiencies resulting from mutations In the gene coding 
for lysosomal spingomyellnase. Niemann·Pick type C (NPQ is an 
autosomal recessive disorder characterized by abnormalities of 
intracellular transport of exogenous cholesterol with sequestration 
of unesterified cholesterol in lysosomes and storage of glycolipids, ... ............. .... ......... ........ ..... ... .. corii.tiiu� on p(Jge"i ·,;.: 
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sphingomyelin and gangliosides in central nervous system. Feline NPC has been clinically, biochemically, and morphologically charac· 
terlzed, and a breeding colony has been established for further characterization and therapeutic trials, including bone marrow transplan· 
tation. 
At least two separate genes induce identical biochemical phenotypes of human NPC. A gene (NPC1) with insertion, deletion and mis­
sense mutations has been identified In the more common form of human NPC; this gene has been mapped to chromosome 18q11. The 
NPCl protein function is not yet known, but has sequence homology to several known proteins involved in cholesterol homeostasis. The 
genetic defect in two murine models has been independently localized to mouse chromosome 18 in a region syntenic to human NPC7 
locus, and the two mouse loci belong to the same complementation group as human NPCl. 
Cell fusions were performed to assess whether multinucleated cells that are formed between human NPC and feline NPC fibroblasts 
showed a reversal of the NPC phenotype. Reversal of the disease phenotype would indicate that the cells each harbor a mutation of dis· 
tinct (unrelated) genes. Conversely, the remaining presence of the NPC phenotype in multinucleated heterokaryons would suggest that 
each of the parent cells (human and feline) harbors a mutation of orthologous genes (NPC1). Cultured fibroblasts from NPC affected 
humans and NPC affected cats were hybridized and then analyzed for complementation by challenging the cells with LDL and subse­
quently staining with flllpln to visualize any abnormal accumulation of unesterified cholesterol. Persistence of positive fllipin staining in 
heterokaryons Indicated an absence of complementation, suggesting that the underlying defect in the human chromosome 18 variant 
and the feline model involve orthologous genes. Studies are currently being conducted to identify the feline ortholog of NPC1 and to 
determine if this gene is disrupted in the feline NPC model. 
Rllowing the identification of a proband, a colony of Maine coon ats With a heritable form of hypertrophic cardiomyopathy HCM) was developed. Selective breedings and periodic echocardiographic examinations were performed to study the 
phenotypic expression, natural history, and heritable characteristics of 
the disease. Phenotypically, the disease is characterized primarily by 
marked papillary muscle hypertrophy, progressive left atrial enlarge­
ment in cats with severe disease, and systolic anterior motion of the 
mitral valve. Approximately half (12122) the offspfing produced by 
mating Maine coon cats from the colony with HCM (affected) to Maine 
coon cats from the colony without HCM (unaffected) developed HCM. 
Breeding affected to affected colony cats produced unaffected cats 
(n=2), affected cats (n=4), and stillborn kittens (n=3). One unaffected 
to unaffected breeding produced two unaffected cats. Equal numbers 
of males and females were affected. Whenever, an affected cat was 
Heritable Characteristics, Phenotypic 
Expression, and Natural History of 
Hypertrophic Cardiomyopathy in Maine 
Coon Cats 
Mark D. Kittleson,' Kathryn M. Meurs,' A. Kittleson,' Marcia Munro,• SH<wang 
Uu,' Jeffrey A. Towbin' 
'University of California, Davis, CA; 'The Ohio State University, Columbus, OH; 
'East Haven, CT; 'The Animal Medical Center, New York City, NY; 'Baylor 
College of Medicine, Houston, TX 
bred to another cat, at least one affected cat was produced. Males and females both transmitted the disease. Multiple instances of male 
to male transmission were identified. This pattern Is compatible with an autosomal dominant trait With 100% penetrance in which the 
stillborn kittens represent lethal homozygotes. In cats from affected to unaffected matings, HCM was not evident before one year of age, 
usually became apparent by 2 years of age, and usually progressed to severe disease by young adulthood (2 to 4 years of age). Males 
in this group developed more severe disease. In cats from affected to affected matings, HCM became apparent as ear1y as 3 months of 
age and progressed to severe disease between 6 and 18 months of age. Males and females in this group both developed severe disease. 
Cats with severe disease died suddenly (n=4) or of heart failure (n=3). FJVe of the seven cats that died were males. At postmortem exam­
Ination, each severely affected cat had moderate to marked myocardial fiber disarray, intramural coronary arteriosclerosis, and interstitial 
fibrosis. We conclude that HCM in Maine Coon cats closely mimics human familial HCM in which sarcomeric gene mutations are respon­
sible for the disease. It most closely mimics the disease observed in human families that have light chain mutations. 
Rmilial hypertrophic cardiomyopathy (FHCM) in humans is a primary disease of the cardiac muscle characterized by concentric hypertrophy of the left ven­tricular walls, dynamic outflow obstruction, and diastolic dysfunction. It is fre­quently caused by a point mutation in the !}myosin heavy chain $MHQ 
gene. All but one of the reported mutations in this gene are found in the region 
that codes for the head of the molecule. Oinical and pathological features of hyper· 
trophic cardiomyopathy (HCM) In the domestic cat closely resemble those of FHCM. 
feine HCM has been demonstrated to be a familial defect inherited as an autoso­
mal dominant trait in some feline families. DNA from cats with familial feline HCM 
was evaluated for the �MHC mutations observed in humans with FHCM. 
Polymerase chain reaction-based sequencing identified nine base pair changes 
within exons 3·23, the head region of the molecule. The base pair changes did not 
affect the amino add produced and were observed with equal frequency in the nor· 
mal cat population. Thus, the identified base pair changes in this gene reflect nor· 
Identification of Nine 
Polymorphisms Within the Head 
Region of the Feline Beta Myosin 
Heavy Chain Gene 
Kathryn M. Meurs,' Mark D. Kittleson,' Wendy A. Ware,• James E. 
Womack', Jeffrey A. Towbin' 
'Ohio State University, College of "'terinary Medicine, Columbus, 
OH, 'University Califomia-Davis, College of Veterinary Medicine, 
Davis, CA, 'Iowa State University, College of Veterinary Medk;ine, 
Ames, /A, 'Texas A & M University, College of Veterinary Medicine, 
College Station, TX, 'Baylor College of Medicine, Houston, TX 
mal feline polymorphisms rather than disease specific mutations. Although a causative mutation was not found in this study, we can not 
rule out the Importance of this gene in some cases of feline hypertrophic cardiomyopathy, since the disease has significant genetic het­
erogeneity between families in humans. Additional studies should also be performed to examine the other candidate genes for this feline 
disease. 
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Erythrocyte P yruvate Kinase 
Deficiency in Cats 
U. Giger,' Y. Rajpurohit,1 B. Skelly,' P. Wang,' S. Fore!,' B. 
K.ohn,' A. Niggemeier,' D.F. Patterson,' P.S. Henthom' 
'Section of Medical Genetics, University of Pennsylvania, 
Philadelphia, PA;'Veterinary Teaching Hospital, University of 
California, Davis, CA 
Rtype pyruvate kinase (R·PK) deficiency is the most common erythroenzymopa· hy in humans. R·PK·deficient dogs represent the only animal model described hus far, but they develop a unique M2·PK expression and terminal osteoscle­osis not typically seen in affected humans. We now describe the clinicopatha: 
logic and biochemical abnormalities as well as the molecular basis of R·PK deficiency 
in cats, a close homologue of the human disease. 
Nine 1 to 10-year-old male and female Abyssinian and somali cats were identified 
with signs of chronic intermittent hemolytic anemia and mild splenomegaly. The ane­
mia was macrocytic-hypochromic and regenerative, and no poikilocytes were seen. The 
osmotic fragility of erythrocytes was normal or slightly increased. Glycolytic metabo-
lites proximal of the PK step were markedly increased in affected erythrocytes when 
compared to controls. Erythrocytic R·PK enzyme activity of affected cats was low but variable with only 6·20% of that in normal cats. 
Parents and other relatives of R·PK-ileflcient cats had intermediate PK actMty, supporting an autosomal recessive mode of inheritance. 
There was a complete absence of R·PK by immunoblotting of erythrocyte homogenates from affected cats. 
The normal R·PK eDNA was sequenced from feline liver eDNA clones and RT·PCR products from normal cats (except for first exon), and 
was found to be 87% and 88% homologous to the human and canine R-PK eDNA sequence, respectively. Furthermore, on Northern blots 
the R·PK message was markedly reduced in reticulocytes from affected cats versus healthy control cats. Gel electrophoresis and sequence 
analysis of RT·PCR products exon 6 of affected cats revealed the existence of a eDNA length polymorphism in this region (13 bp deletion). 
Subsequent sequence analysis of genomic DNA spanning the same region led to the identification of an intronic G -+ A transition of affect· 
ed cats. This transition may be involved in altering the donor splice site selection of intron 6 and hence lead to the use of cryptic splice 
sites located nearby, resulting in a frameshift and premature stop codon. These studies permit the accurate diagnosis and genetic control 
of PK deficiency in Abyssinian and Somali cats and allow the development and evaluation of gene transfer for this common erythroen· 
zymopathy. 
Feline MPS VI as a Model to Study 
Pathology and Evaluate Efficacy 
of Therapy for Maroteaux-Lamy 
Syndrome Patients 
John J, Hopwood, Allison C. Crawley, Sharon Byers, Gouri 
Yogalingam, Julie Bielicki 
Lysosomal Diseases Research Unit, Womens and Childrens 
Hospital, North Adelaide, South Australia 5006, Australia 
M ucopolysaccharidoses(MPS) are a group of ten inherited lysosomal star· age disorders characterised by an inability to degrade specific mucopolysaccharides. Mucopolysaccharldosis type VI(MPS VI) results from a deficiency in N·acetylgalactosamine-4-sulfatase(4S) leading to 
lysosomal storage of the mucopolysaccharide dermatan sulfate in connective tis­
sue cells and dermatan sulfate-uria. Children with MPS VI display a range of phe­
notypes from extremely severe, with multitissue involvement, to attenuated clinical 
forms. The skeletal system is a major site of pathology in MPS VI children. This 
pathology includes dwarfism, facial dysmorphia and dysostosis multiplex. 
Widespread soft tissue pathology includes heart valve thickening corneal clouding 
joint stiffness and enlarged liver and spleen. Severely affected patients usually die 
before twenty years from cardiac or respiratory complications. MPS VI has also 
been described In cats with the clinical and tissue pathology closely paralleling that observed in humans. These cats provide a valuable 
model to investigate the pathophysiology of MPS VI and to develop and evaluate the efficacy of new therapies for use in humans. 
We have identified two mutations in our feline MPS VI colony originally obtained from Siamese cats first described in Philadelphia. 
Homozygous L476P alleles cause a severe clinical presentation with osteopenia, whereas L476P/D520N cats have normal growth with 
a high incidence of degenerative joint disease. L476P/L476P MPS VI cats, treated with weekly injections of recombinant human 4S from 
birth for six months, showed a dose responsive effect of enzyme replacement with a complete reduction of lysosomal storage vacuoles 
in all soft tissues except cartilage and cornea. Treated cats were heavier, more flexible, without spinal cord compression, and had an 
improvement in most pathologies associated with MPS VI except degenerative joint disease. Treatment with recombinant feline 45 gave 
a significantly improved dose response over the human 4S equivalent We anticipate that the benefits observed in these studies will also 
be observed in human MPS VI patients who undergo enzyme replacement therapy. 
Construction and Analysis of Bacterial 
P1 Artificial Chromosome Libraries 
from the Domestic Cat 
Thomu W. Beck', Naoya Yuhki', Leslie Lyons', N. Pieter DeJonh', and 
Stephen O'Brien> 
'JRSP, SAIC-Frederick;'Laboratoty of Genomic Diversity, NCI, Frederick 
Cancer Research and Development Center, Frederick, MD; 'Roswell Park 
Memorial Cancer Institute, Buffalo, NY 
]e domestic cat serves as a model for over 30 heritable genetic 
efects which are analogous to human genetic diseases, and the 
omestic cat is subject to epidemics of two viruses, FeLV and FIV, 
that cause immunodeficiencies and neoplasms, providing a useful 
animal model for the study of virus and host genome interactions. 
Artificial chromosome libraries have become essential research tools for 
positional cloning of disease genes. Although yeast artificial chromosome 
libraries have been a method of choice because of their large insert size, 
the advantages of bacterial chromosome vectors for genomic cloning in 
terms of lower frequency of chimeraerism, higher transformation efficien-
cy and ease of purffication from host genome has made these vectors 
increasingly important. Bacterial artificial chromosome vectors consist of a single copy replicon for stable propagation of large insert clones 
derived either from fertility factor (BAQ or bacteriophage Pl (PAQ, an antibiotic resistance gene for positive selection of vector containing 
clones and a SacBII domain for positive selection for recombinants. 
8 Feline Practice • Supplement 1 999 
.. ..................... . . . . . . . . . . . ................. ciiiiunue'do'ii·;.;o9e·9·>· 
Continued from page 8 -
We have constructed a domestic cat genomic DNA library composed of 91,900 independent PI artificial chromosomes (PACs) with an 
average insert size of 80,000 bp and a size range of 50·150 kb as determined by pulsed field gel electrophoresis of 35 random clones. 
The theoretical number of genome-equivalents represented was estimated at 2.5 and the probability of finding any given gene sequence 
as 91%. Screening of the feline PAC library with 52 Comparative Anchor Tagged sequences (CATS) using the polymerase chain reaction 
(Lyons, et al., Nature Genetics 15:47,1997) and comparison with PCR products obtained using cat genomic DNA by agarose gel elec· 
trophoresis indicated that the actual probability of finding any given gene is -83%. This cat genomic PAC library has been successfully 
screened for feline MHC class I and class II genes and the clones characterized using high-throughput mini preparations in a 96-well plate 
fonnat for rapid isolation of BAGPAC/plasmid DNAs, clone-based physical mapping, and nucleotide sequence analysis. A feline BAC 
library consisting of 150,000 • 200,000 colonies with 150 kb inserts for an 8 • 10 fold redundancy is currently under construction which 
will be arrayed into 384-well mictotiter plates and made available to the feline genetic disease community. 
Hemoglobin Polymorphism 
I 
I t has been reported that cats have 2 major types of hemoglobin (Hb} named HbA (a2W� and HbB (a2W2). HbA and HbB have iden­tical «"globin chains, but W differs from 13" by four amino adds, and only 13" is acetylated at the amino tenninus. The HbA:HbB ratio 
appears to vary between different cats from 45:55 to 95:5. Alleles for 
high and low expression of 13" were thought to detennine the Hb ratio. 
B. Kohn', M.P. Reilly', T. Asakura', A. Niggemeier', P.S. Henthorn', U. Giger' 
In order to further characterize the feline Hb system, we analyzed 
feline Hbs by isoelectric focusing electrophoresis, by reversed-phase 
high perfonnance liquid chromatography (RP·HPLQ and by Southern 
'Section of Medical Genetics, School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia and 2Children's Hospital, Philadelphia, PA; 'Clinic for 
Small Animals, Freie Universitat Berlin, Berlin, Germany 
blotting, cloning and sequencing of the �-globin gene region. Hemolysates from 84 cats of different breeds, gender, and age were ana· 
lyzed. Twelve families were included into the study. 
Consistent with previous reports using other techniques a single a-globin was found by RP·HPLC. However, by RP-HPLC analysis a total 
of 6 �-globins (I to VI) was identified, with each cat having 1 to 4 �-globin chains. From analysis of the number of !}globins, their relative 
amounts, and Hb miXing studies, 17 �-globin patterns were observed. The �-globin pattern in healthy and anemic cats was identical. 
Family studies documented an autosomal codominant mode of inheritance of the adult !}globins and a linkage of 2 �-chains fanning 
haplotypes. Analysis of the �-globin gene region by Southern blotting using a human !}globin DNA probe revealed multiple DNA restric· 
tion fragment length patterns providing further evidence for the complex !}globin system. 
In conclusion, evidence for the greatest polymorphism of adult �-globins thus far described in any species is provided. A feline !}glo­
bin gene region with 2 linked !}globin gene loci and 2 and 5 alleles is proposed. 
M embers of a family of domestic shorthaired cats showed fasting chy­lomicronemia with hypertriglycridemia and hypercholesterolemia. Affected cats showed fasting hyperlipemia, lipemia retinalis and xan· thomas in skin and other tissues. Peripheral neuropathies due to com· 
pression of nerves by xanthomas was a significant clinical sign. Reduced body 
mass, slowed growth rates and increased still birth rates were observed in kittens 
homozygous for the mutation and reduced oral fat tolerance in homozygotes and 
heterozygotes. Homozygotes show reduced LDL -c and elevated (male) HDL-C. The 
fat content of milk of homozygotes contains 25% of that of normal cats with enrich· 
ment in shorter chain fatty acids (C14:0, 16:0). Biochemical analyses confirmed that 
the cats had defective lipoprotein lipase (LPL) catalytic activity in the presence of a 
Chylomicronemia & I nherited 
Lipoprotein Lipase Deficiency 
in Domestic Cats 
Boyd R. Jones', David G. Ginzingel', Suzanne Lewis', 
Michael R. Hayden' 
'Department of Small Animal Clinical Studies, University 
College Dublin, Ireland;' Department of Medical Genetics, 
University of British Columbia, Vancouver, Canada 
high level of LPL mass. The cats produce an abnormal LPL protein which is inactive and fails to bind to the vascular endotheli· 
urn. Cloning the normal and affected cat LPL eDNA has shown that the affected cat has a nucleotide change resulting in a sub­
stitution of arginine for glycine at residue 412 in exon 8. In vitro mutagenesis and expression studies, in addition to segrega­
tion analysis, have confirmed that the DNA change is the cause of LPL deficiency. There is an autosomal recessive mode of 
inheritance with heterozygotes having intermediate LPL enzymatic activity. These cats are a model of human LPL deficiency and 
may be useful for the new approaches for treatment of LPL deficiency, including gene therapy. 
Hypertrophk fel1ne muscu�r dystrophy (HFMD) is due to an lnherllffl X<lnked Dystrophin-Deficient recessive dystrophin deficiency and is a homologous animal model for the human disease Duchenne (DMD) muscular dystrophy, a crippling condition leading to Hypertrophic Feline Muscular muscle atrophy and fibrosis and premature death of affected young men. Dystrophy in the Cat 
Dystrophin, a rod shaped protein, is present in the subsarcolemmal space. It may exert sev-
Frederic P. Gaschen 
era! effects on penneability, mechanical protection or calcium regulation, although its exact 
function remains unclear. Clinic for Companion Animals, Faculty of Veterinary 
Remarkably, the phenotype of dystrophin deficiency in cats is characterized by pro- Medicine, University of Berne, Berne, Switzerland 
nounced and potentially lethal appendicular and axial muscle hypertrophy, with involve-
ment of the tongue and diaphragmatic muscles. We studied the clinical course of the dis· 
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ease in our colony of HFMD cats. Affected kittens first show an increase in serum CK levels at age 5·6 weeks. Hypertrophy of axial and 
appendicular muscles becomes obvious around 3 months of age. Muscle hypertrophy is durable. Serum concentrations of musde 
enzymes such as CK, AST but also ALT are consistently increased. Hypertrophic cardiomyopathy develops with ultrasonographic myocar­
dial changes indicative of multifocal mineralization. However, these cats usually do not show dinical signs of heart failure. Typical EMG" 
changes consist of bizarre high frequency discharges. Some of the cats are very sensitive to various stresses including volatile anesthetic 
agents or simple restraint, and develop stress-related lethal peracute rhabdomyolysis. Histologically, the diseaSe is characterized by mul· 
tiple foci of muscle fiber degeneration and regeneration without significant inflammatory infiltrate, and myofiber hypertrophy. Dystrophin 
immunoblots show muscle dystrophin concentration reduced to less than 10 percent of normal in skeletal muscle, and no dystrophin in 
heart muscle. In spite of its different phenotype, HFMD is an interesting and original model particularly for the earty stages of human dys· 
trophinopathies. 
Glycogen Storage Disease Type IV 
In Norwegian Forest Cats: 
Molecular Detection of Carriers 
John C. Fyfe, R.L. Kurzhals 
College of Veterinary Medicine, Michigan State University. East 
Lansing, Ml 
G
lycogen storage disease type IV (GSD IV) is an autosomal recessive dis­
order due to glycogen branching enzyme (GBE) deficiency In humans 
and Norwegian forest cats. In cats, phenotypic variation included fatal 
cardiopulmonary collapse at birth or progressive neuromuscular degen· 
eration beginning at 5 months and causing complete debilitation by 10 months 
of age. Sudden, fatal cardiac decompensation was observed in a 1 -year-old cat 
Though not in stillborn kittens, deposition of abnormal glycogen in skeletal and 
cardiac muscle and in neurons coincided wtth tissue degeneration in jtNeniles. 
Uver and smooth muscle cells showed no evidence of pathology other than accu· 
mulation of abnormal glycogen. Feline GBE eDNA was cloned, and molecular characterization of feline GSD IV demonstrated lack of 
immunoprecipitable GBE in liver, undetectable GBE RNA on northern blots, variant GBE spicing products detected by RT·PCR, and 
restriction fragment length differences evident on Southern blots (in preparation). 
These data s�ggested deletion of an exon of GBE on the GSD IV allele. To examine this hypothesis and to develop convenient GSD 
IV carrier detection in clinically normal Norwegian forest cats, we PCR·amplified genomic DNA from normal and affected cats across 
the putative deletion. Sequence of the products demonstrated a complex rearrangement that created a 230 bp insertion immediately 
s· of a 6 kb deletion, eliminating a 172 bp exon. A common forward primer and allele-specific reverse primers were designed to PeR­
amplify 315 and 254 bp products from normal and rearranged GSD IV alleles, respectively. In a family study, all affected cats were 
homozygous for the GSD IV allele, obligate carriers exhibited both normal and GSO IV alleles, and 50 unrelated normal cats were 
homogygous for normal alleles. The PCR based, allele-specific carrier test of blood samples submttted by Norwegian forest cat breed­
ers detected carriers in three such catteries. Examination of pedigrees did not reveal a common ancestor for all detected carriers, sug· 
gesting either misidentified parentage or dispersion of the GSD IV allele in the breed prior to importation to the USA. This test is avail­
able to breeders of Norwegian forest cats to eliminate the GSD IV allele from breeding stock. 
Fel ine Cytogenetics: Karyotypes, FISH 
and Painting 
Wntlam Nash', Joan Menniger', William Modi', Johannes Weinberg', Stephen J. 
O'Brien' 
'H & W Cyotgenetics, Lovettsville, VA; 'SAIC-FCRDC, Frederick, MD; 
'Cambridge University, Cambridge, UK; 'Laboratory of Genomic Diversity, 
Na/ional Gancer Institute, FCRDC, Frederick, MD 
T
he domestic cat has 38 chromosomes, 18 autosomal pairs 
and the X and Y. G·banding of the domestic cat and its 
feline relatives have shown the karyotype to be highly con­
served across all felids. Thirty-three of 37 felid species 
have been G-banded by several investigators and 13 chromosomal 
species groups can be established based on eight polymorphic 
autosomes. Approximately two-thirds of the felid species can be 
combined into three large groups. Most of the large cats have the 
same G-banded pattern and include the panthera and lynx genus· 
es. Most small cats of the Felis genus are in a second group and a 
third group accounts for several large and small cats including the Jeopard cat, cougar and jaguarundi. Early G-banded and mapping 
data showed that at least human chromosomes 1 p, 2, 12, and X where extremely conserved to cats and a majority of the felid chro­
mosomes have been suggested to represent the ancestral carnivora chromosomes. The shared homology of genetic structure is also 
conserved at the sequence level between cats and humans. Dozens of human and cat specific coding gene loci and microsatellites 
have been hybridized to feline metaphase spreads, further demonstrating the conservation in gene sequence and positions between 
the two species. Most recently, the feline chromosomes have been flow sorted and individual chromosome paints have been estab­
lished. Feline chromosomes have been hybridized to the human karyotype and human chromsomes have been hybridized to cats. 
These data show that as few as ten rearrangements of the cat karyotype can transform the genome to a human karyotype. The cyto­
genetic data have supported the gene mapping data of the strong conservation between humans and cats and these techniques are 
continuing to resolve the feline genetic map using both feline radiation hybrids and interspecies hybrids. 
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Te gangliosidoses are fatal inherited diseases affecting iamese, Korat and non-purebred cats. Although the first eport of a feline gangliosidosis was published in 1971, their molecular bases have been discovered only recently, provid· 
ing an unprecedented opportunity to apply molecular diagnoses for 
carrier detection. GMl and GM2 gangliosidosis result from muta­
tions in the respective genes (GALS, HEXA or HEXB) encoding one of 
the lysosomal enzymes @-galactosidase, N-acetylhexosaminidase A 
or B) responsible for degrading either GMl or GM2 ganglioside. 
Feline GMl gangliosidosis affecting Siamese cats results from a G to 
C substitution (CGT > ccn at base 1486 resulting in a change of an 
The Molecular Bases of Feline GM1 and 
GM2 Gangliosidoses 
Henry J. Baker,DVM', Bruce F. Smith, VMD, PhD', Douglas R. Martin, PhD', 
Polly Foureman, PhD', Massimo Castagnaro, DVM, PhD', G.S. Varadarajan, 
PhD', Melanie Georgeson' 
'Scott-Ritchey Research Center, College of VeterinatY Medicine, Auburn 
University, Auburn, AL; • Department of Animal Pathology. VeterinatY Faculty. 
University of Torino, Torino, Italy 
amino acid from Arg to Pro and loss of hydrolytic activity. Recently, we have shown that the same mutation is responsible for GMl 
gangliosidosis in both Siamese and Korats. Both feline GM2 gangliosidoses described to date result from different mutations of the 
HEXB gene and loss of all hexosaminidase activity measured by hydrolysis of synthetic substrates. The Korat mutation (fHEXBkorat) 
results from a deletion of cytosine at base 39 resulting in a premature stop codon and very early termination. In contrast, the second 
mutation observed in non-purebred cats (fHEXBbaker) results from a 25 base inversion at the extreme 3' end of the open reading 
frame, causing cessation of translation only 8 amino acids premature of the full length protein. Immunologically cross reactive protein 
is present, but hydrolytic activity is lost. Remarkably, both GMl and GM2 gangliosidoses occur in the Korat breed, complicating clini· 
cal and pathological diagnoses of similar diseases caused by entirely different mutations. Although these diseases can be diagnosed 
by enzyme assays, there is sufficient overlap between carrier and normal biochemical phenotypes that indeterminant results are fre­
quent, complicating use of the enzyme results for breeder selection. Therefore, unambiguous molecular testing is critically important 
to detect carriers and encourage their elimination from breeding stock. International screening of Korats for the gangliosidosis muta­
tions is currently in progress. 
Spontaneous ADPKD in Persian cats closely resembles the human disease. In cats with ADPKD, renal function gradually deterioraties leading to end· stage renal disease by 3·10 years of age. Diagnosis was based on ultra· sonography, gross and microscopic renal pathology, or both. Results of 
Chi square analysis were compatible with autosomal dominant inheritance. Renal 
cysts were lined by cuboidal or squamous epithelium and chronic tubulointersti· 
tial nephritis was present in most affected cats. Biliary hyperplasia and fibrosis 
were observed in the livers of many affected cats. Na•-K• ATPase immunohisto­
chemistry showed strong basilar staining of thick ascending limbs and distal 
tubules and weak basilar staining of proximal tubules. Less than half of the cysts 
Autosomal Dominant Polycystic 
Kidney Disease in Persian Cats 
stained for Na+-K• ATPase. Staining with peanut agglutinin suggested that cysts 
were derived from both proXimal and distal nephron segments. 
S.P. DIBartola', K.A. Eaton', M.A. Menotti-RaymoncP, D.S. Biller', 
M.L. Wellman', M.J. Radin' 
'College of Veterinary Medicine, Ohio State University, Columbus 
OH;'LaboralofY of Genomic Diversity, National Cancer lnstituts, 
Frederick, MD 
Primers designed from exons 36 and 37 of human PKDl were amplified in domestic cat DNA generating a 200 bp product Coding 
regions are conserved bearing 86% homology between cat and human sequences. The intronic region is 66% conserved between the 
two spedes. A sequence polymorphism between domestic and leopard cat, identified in the intronic region, was genotyped in a 1 10 
member interspecies pedigree using single stranded conformational polymorphism. ApproXimately 250 polymorphic microsatellites 
have been genotyped and are currently in linkage analysis. One dinucleotide repeat locus, FCA476 was identified which is linked to 
feline PKD1 at lOon with a 1.00 of 4.0. The locus is moderately heterozygous exhibiting an average heterozygosity in a sample of 
outbred domestic cats of 0.64. FCA476 will be genotype<! in the Ohio State Persian cat pedigree and examined for linkage to a puta· 
tive disease locus. The pedigree also will be genotyped and examined for linkage to a putative disease locus with an additional 25 
mlcrosatellites mapped to cat Bl which has conserved synteny with human chromosome 4, the location of PKD2. 
genetic linkage map of the domestic cat has been constructed of 
253 microsatellite loci including 246 autosomal and 7 X-linked 
loci. Two hundred thirty five dinucleotide (dCdA)n (dG.dl)n and 18 
etranucleotide repeat loci were genotyped in a 3·tamily, 107 
member multi- generation interspecies pedigree between the domestic cat 
lfelis catus) and the Asian leopard cat (Prionai/urus bengalensis) Two hun· 
dred twenty nine loci were linked to at least one other marker with a LOD 
soore, 3.0, identifying 34 linkage groups. Unkage groups were physically 
mapped using a somatic cell hybrid panel to 17 of the 19 cat chromosomes. 
An average intermarker distance of 1 1 .3 eM was observed and the estimat­
ed length of the sex-averaged map is approXimately 3400 eM. 
l 
A Genetic Linkage Map of 
Polymorphic Microsatellites in the 
Domestic Cat (Felis catus) 
Marilyn Menotti-Raymond', Victor A. David', Leslie A. Lyon$', Alejandro 
A. Schaffer', James F. Tomlin', Stephen J. O'Brien' 
'Laboratory of Genomic Diversity, NCI-FCRDC, Frederick, MD; 
'NHGRVIDRB, National Institutes of Health, Bethesda, MD; 
'CIT/CBELJBIMAS; National Institutes of Health, Bethesda, MD 
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Assisted Reproductive Technology for 
Facilitating Management of Feline 
Hereditary Disease Models A
ssisted reproductive technology, including electroejacula­
tion, artificial insemination (AI), in vitro fertilization 0Vf), 
embryo transfer (El), and spenn/embryo cryopreservation, 
could be useful for assisting in the propagation and man-* 
agement of valuable feline hereditary disease models. For many dis­
ease models, affected cats have skeletal defonnities or other patho­
logical defects that preclude natural reproductive processes such as 
copulation, conception, gestation and/or parturition. In addition, 
maintenance of viable research colonies for each hereditary model is 
extremely expensive, especially for autosomal recessive conditions 
that require large heterozygous populations for continued propaga-
William F. Swanson', Mark E. Haskins', Mary A. Thrall', Henry J. Baker', 
JoGayle Howard' 
'Cincinnati Zoo and Botanical Garden, Cincinnati, OH; 'University of 
Pennsylvania, Philadelphia, PA; •colorado State University, Fort Collins, CO; 
'Aubum University, Aubum, AL; •National Zoological Park, Washington, DC 
tion. Recent research advances suggest that assisted reproductive 
technology has the potential to become a cost-effective, efficient means for sustaining these various models. In studies conducted at 
the University of Pennsylvania, Colorado State University, and Wake Forest University, semen was collected via electroejaculation from 
cats (n=36 males, 104 ejaculates) representing nine disease models: mucopolysaccharidosls (MPS-1, MPS-VI), a·mannosldosis, Gm1 
gangliosidosis, Ehlers-Danlos syndrome, porphyria, spasticity syndrome, Chediak·Higashi syndrome, and Niemann·Pick (Type Q. Semen 
evaluation revealed that all males produced spennic ejaculates with adequate spenn motility (50·80%), but with variable spenn con· 
centration (2D-650 mllliom/ml) and percentage of nonnal spenn (30·70%) per ejaculate. Recovered spenn were either used fresh for 
AI or extended with cryoprotectant and frozen by pelleting on dry ice. Intrauterine AI of queens stimulated with exogenous 
gonadotropins has proven useful for generating viable offspring in non-model domestic cats. In studies conducted at the University of 
Pennsylvania and Colorado State University, females representing several hereditary diseases (MPS·I, MPS·VI, porphyria, spasticity syn· 
drome) were subjected to intrauterine AI via laparoscopy or laparotomy. Insemination of MPS models (n=32) with fresh spennatozoa 
collected from both MPS·affected and MPS-carrier males resulted in 13 pregnancies (-41 %) whereas AI of MPS model females (11=6) 
with frozen-thawed spenn produced 2 pregnancies (-33%). Insemination of porphyria (n=l) and spasticity syndrome (n=1) models 
with freshly-collected sperm also produced pregnancies. An alternative method for model propagation involves the use of IVF and 
embryo cryopreservation combined with ET. One advantage of this technology is that IVF may allow generation of homozygous 
embryos that can be transferred to non-model recipients to produce affected kittens exclusively. In addition, using embryo cryop­
reservation, disease models may be maintained entirely with genome resource banks until needed for research purposes. Our ongo­
ing studies with M PS populations are demonstrating the feasibility of this approach. In a recent trial, M PS·I and M PS-VI affected females 
(11=4) and non·MPS females (n=2) were treated with exogenous gonadotropins and oocytes were recovered from ovarian follicles via 
laparoscopy. Oocytes (mean ± SEM, 1 1.8 ± 1 .5 oocytes/queen) were inseminated in vitro with spenn collected from MPS-affected (11=2) 
or non-MPS (n=2) males, and resulting embryos were cultured for 6 days. Fertilization percentage was similar for MPS-homozygous 
(67%) and heterozygous (41%) combinations, and embryos from each demonstrated comparable development (14.5 ± 2.8 and 16.6 
± 2.3 cells/embryo, respectively) after 6 days of culture. In follow-up studies, IVF embryos derived from MPS-affected cats will be cry­
opreserved, transported to the Cincinnati Zoo and transferred into non-MPS recipients to produce offspring. Andings from earlier 
embryo transfer trials with non·MPS cats suggests that, if post·thaw embryo viability is adequate, we may expect pregnancy success 
at least equivalent to that observed following AI. In conclusion, assisted reproductive technology, when fully developed, should facili­
tate efficient management of cat research colonies and be applicable to a variety of feline hereditary disease models. 
Supporled by NIH grants RR 0009801, DK 25759, RR 02512, RR 06886, NS 10967 and RR 00045 
The Heritabil ity of Susceptibility to 
Infectious Disease in Domestic Cats 
Janet E. Foley 
School of Veterinary Medicine, Center for Companion Animal Health, University 
of California, Davis, Davis, CA 
D omestic cats are commonly affected by bacterial, viral, pro­tozoal, and other infectious agents, particularly in multiple­cat settings such as shelters, catteries, and feral cat colonies. To the extent that susceptibility has a genetic 
component the problem has been exacerbated in catteries where cat 
breeding populations may be small, mating may be strictly regulat­
ed, and artificial selection may be intense, leading to small effective 
population sizes (NJ. In cats it is difficult to evaluate the heritability 
of susceptibility to infectious disease for two reasons. Infectious disease susceptibility may appear in obscure patterns on pedigrees in 
part due to reduced penetrance because of uneven exposure among cats to the infectious agents. Secondly, selection experiments to 
determine the heritability to infection in cats have not been performed. Whether or not the heritability is precisely known, it would be 
possible to reduce the incidence of infectious diseases in cats by artificial selection. Artificial selection is commonly applied to charac­
ters of conformation in cats, but rarely for resistance to infection. The current presentation discusses parallel studies in mice and other 
animal models and the limited data available for feline susceptibility to infectious disease. The feline enteric coronavirus model sys· 
tern is described in detail as an example of the approach to the study of feline genetics and infectious disease. Approaches are sug· 
gested that might enable us to estimate the heritability of susceptibility to infectious disease and evaluate the success of selection 
regimes for increasing resistance. 
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Hereditary Eye Diseases 
Kristina Narfstrom I n comparison to the dog species, cats are affected by relatively few inher­ited eye diseases. However, several specific problems of the anterior and posterior structures of the eye have been described especially in pure­bred cats. Below is a short description of the most common defects diag­
nosed in cats in which a hereditary background is suspected or has been 
proven. 
Department of Medicine and Surgery, Swedish University of Agricultural 
Sciences, Faculty of Veterinary Medicine, Sweden 
• Eyelid agenesis is a developmental defect of cats which nearly exclu­
sively affects the upper, lateral eyelids. Iris, lens and optic nerve colobomas (notches) may be present concurrently. The defect is most 
often seen in Birman and in Burmese cats but may affect any breed. 
• Epibulbar dermoids are also congenital malformations, which result in displacement of skin elements, often in the lateral angle of 
the eye. Again Birman and Burmese cats are often affected although the defect can occur in other breeds as well. 
• Entropion is an inward turning of the lower eyelid which causes hairs from the surrounding skin to rub on the cornea. Only part 
of the eyelid may be affected or the entire lid. Persian cats are most often affected. 
• Corneal sequestrum (black body) is a condition of unknown cause that is unique to the cat. There is a breed disposition in that the 
condition, which often is bilateral, is seen in Colorpoint, Persian, Siamese, Himalayan, Birman and Burmese cats. Mixed breed cats may 
also be affected with a unilateral condition, which indicates that other factors such as chronic irritation or tear film deficiencies may be 
involved in the disease mechanism. 
• cataract is an opacity of the lens or its capsule which is infrequently seen in the cat species. Congenital cataract has been report­
ed in the Persian and British shorthaired breeds and presumed to have an autosomal recessive inheritance. cataracts secondary to 
inherited progressive retinal atrophy (PRA) are not seen in cats. 
• Retinal dysplasia (RD) is an abnormal development of the neural retina and can involve more or less widespread parts of the reti­
na. In cats mainly the focal type of RD is seen which usually does not cause any visual problems. cases of RD have been found spo­
radically and especially in the Abyssinian. 
• Inherited enzyme deficiencies or retina as well as other body systems. The recessively inherited diseases include alpha-mannosi­
dosis, minifested in the central part of the fundus, GM !-gangliosidosis, associated with focal fundus lesions and gyrate atrophy 
(ornithine deficiency), resulting in PRA. 
• Chediak·Higashi syndrome (CHS) is an autsomal recessive disease of cats and other species. Eyes of CHS affected kittens are 
hypopigmented and there are changes in retinal structures. A membrane defect has been reported in CHS, involving an increase in 
unsaturated fatty acid content 
• PRA has been reported in only a few breeds of the feline species. Retinal degeneration with a suspected hereditary basis has been 
reported in Siamese, Persian and in mixed-breed domestic cats. Only in the Abyssinian cat has the mode of inheritance for the defect 
been proven. PRA in Abyssinian cats can be inherited either in an autosomal recessive mode or as an autosomal dominant trait The 
former type of disease appears to be more common in the general population of Abyssinian cats, especially in northern Europe. The 
disease in the recessive form is a slowly progressive disorder clinically affecting cats at the age of 1 .5 to 2 years of age but leading to 
blindness at 3-5 years of age. In the latter type of disorder affected cats are congenitally visually impaired, some have nystagmus and 
severe visual impairment or blindness at the age of 1 2-16 weeks. 
I n order to develop a genetic and physical map of the domestic cat MHC, we have constructed a PAC (P1 artificial chromosome) library from a male domestic cat genomic DNA. This library consists approximately 80 Kb average 
insert size and 2.5 times genome equivalent complexity. 
Utilizing this library and domestic cat MHC eDNA and PCR 
clones as probes, we have isolated 250 Kb class I I  and 330 
Kb class I feline MHC region. Restriction mapping using end 
labeling method and high-throughput shotgun sequencing in 
96 well plate format revealed that the isolated class I PAC 
clones have 4 contigs, while class I I  PAC clones contain three 
Characterization of Genomic Organization in 
Feline MHC Class I and II Region Using 
Feline PAC Genomic Library 
N. Yuhki, T. Beck, S.J. O'Brien 
Laboratory of Genomic Diversity, National Cancer Institute, Frederick Cancer Research 
and Development Center, Frederick, MD 
contigs. These class I I  contlgs included DPA, DNA, RING3 and DMA genes; LMP2, TAPl, LMP7, TAP2 and DOB genes; ORB and ORA 
genes in DR subregions. Comparison of gene organization in human, mouse, and cat MHC class II regions showed that mouse and 
cat class II regions are much more compact than human class II region, approximately 50 % size of human HLA for mouse H2 and 
60 Ofo for cat MHC One feline PAC clone (75.6 Kb) contained a single ORB and a single ORA genes with 17 Kb interval sequence 
and also 5' region of this ORB gene had a high sequence homology specific to human DRBl functional gene, suggesting that this 
cat MHC DR subregion has very simple gene organization. 
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Feline a.-Mannosidosis: From Molecular 
Genetics to Therapy 
S.U. Walkley', K. Dobrenis', D. Siegel', M. A. ThraiP, T. Berg', 0. Tollersrud', 
0. Nilssen' 
'Albert Einstein College of Medicine, Bronx, NY, 'Colorado State University, Fort 
Collins, CO, and 'University of Tromse, Tromse, Norway 
]e lysosomal storage disease, a-mannosidosis, was first 
escribed in humans in 196Z Caused by a genetic deficien· 
cy of lysosomal a·mannosidase, the disorder is characterized 
by psychomotor retardation, deafness, hepatomegaly,. 
increased susceptibility to infections, and partial dysostosis multiplex. 
Feline a·mannosidosis was first recognized independently by 
Blakemore and by Vandevelde in  the early 1980's and several 
breeding colonies have been established. The gene for feline lyso-
somal a·mannosidase has been identified and the defect in our 
colony of cats with a-mannosidosis determined. The enzyme is synthesized as a single chain precursor with a 50 aa signal peptide fol· 
lowed by a polypeptide chain of 957 aa, with the latter being cleaved into three polypeptides in the mature state. In our mutant kit· 
tens, a 4 base pair deletion was found to result in a frame shift and premature termination, and the production of a truncated protein 
with little or no hydrolytic activity. Absence of lysosomal a-mannosidase results in storage of a variety of mannose-rich compounds in 
essentially all cells of brain and other tissues. There is also an unexplained accumulation of the glycosphingolipid, GM2 ganglioside, 
in many, but not all, CNS neurons in diseased cats. In addition to lysosomal storage, GM2 ganglioside-laden pyramidal neurons of the 
cerebral cortex sprout synapse-bearing ectopic dendrites identical to those documented in primary ganglioside storage diseases. We 
have also found that GABAergic neurons of cerebellum and other brain regions exhibit massive neuroaxonal dystrophy in a manner 
that closely correlates with clinical neurological dysfunction. Our attempt at developing therapy for this disease has involved use of 
bone marrow transplantation (BMn with sibling kittens serving as donors. Affected kittens transplanted at 8·12  weeks of age revealed 
reversal of mild tremors present at the time of transplant, and failure to develop additional clinical neurological disease over long peri­
ods of time (currently 7 years). Our studies showed that BMT successfully delivered enzyme to CNS neurons and eliminated storage. 
This likely occurred via monocyte migration to brain and secretion of stable enzyme that was internalized by diseased brain cells. Feline 
a-mannosidosis represents the most successful example of correction of a lysosomal storage disease with brain involvement and has 
led the way in deVelopment of potential therapies for other genetic brain diseases. 
Development Strategies for DNA-Based 
Tests for Cat Parentage Verification 
Ann T. Bowling 
Veterinary Genetics Laboratory, School of Veterinary Medicine, University of 
Galifomia, Davis, CA 
]e genetic heritage of a registered cat is described by its 
pedigree. Owners highly value the ancestry records to pro­
ide information about their cats' expected potential. 
arentage testing programs are a tool to help breeders attain 
their breeding goals by assuring pedigree accuracy, by providing 
highly effective solutions to paternity questions and by sorting out 
switched kitten scenarios. 
Cat fancy associations and owners interested in parentage testing 
may wish to take advantage of the new generation of genetic tests 
based on assays of inherited DNA sequence differences between individuals. A testing system that meets the needs of cat breeders 
and their registration authorities is likely to be similar to ones successfully used for DNA-based parentage tests of horses, cattle and 
other domestic animals. Characteristics of these genetic tests include: 
• the genetic variants (alleles) detected show simple Mendelian inheritance, with a large amount of genetic variation (polymorphism) 
within breeds and a low frequency of undetectable (nulij alleles; 
• the typing procedures are fast, relatively inexpensive and can be automated; 
• the detection systems provide highly reproducible and accurate results and do not use radioactive (isotopic) labeling; 
• the tests require small amounts of DNA and are not limited to fresh blood; 
• the alleles are characterized by a low mutation rate; 
• the systems are genetically independent (unlinked); 
• the alleles detected can be simply encoded for computer data storage and easy retrieval. 
Currently only microsatel lites have proven to have the spectrum of genetic properties needed for large-scale animal parentage ver· 
ification programs. A microsatellite is a DNA segment characterized by simple repeat motifs. Based on the effective tests in other 
domestic animal species, the cat DNA parentage test will likely consist of 10-15 microsatellites. The efficacy of this test to detect incor· 
rect parentage should be very high-calculated to be 99.99% or greater. Such an array of markers should be effective even in circum· 
stances involving inbred pedigrees, a consistent feature of domestic animal breeds. With such a test, it is highly unlikely that any two 
cats except identical twins (if they exist) will have the same type. The test will be able to be periormed using a variety of biological 
samples, but the routine cat test will probably use mouth swab samples. These samples can be taken by the owners, without the need 
for veterinary assistance, and sent to the laboratory by first class mail with no risks of breakage or of spoilage due to extremes of heat 
or cold. 
With the availability of a parentage test, cat breeders may more effectively attain their breeding goals through verified pedigrees, 
and will have access to highly effective tools to sort out paternity questions and switched kitten scenarios. 
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Feline Amyloidosis Rline amyloidosis is a rare finding. In Abyssinian/Somali and iamese/Oriental breeds, however, it is more common while eing of the reactive type (AA-amyloidosis). The amyloid-A protein is derived from an acute phase protein of hepatic 
origin, serum amyloid A (SAA). For this protein in mammals differ­
ent isotypes have been found. The exact pathogenesis of AA-amy­
loid deposition from the acute phase SAA is unknown. For the 
Abyssinian breed renal amyloidosis has been mentioned as major 
clinical problem in several papers; the Siamese amyloidosis has 
not received broad attention sofar. The present report regards the 
Erik Gruys', M. Van de Stadt', J.J. Blok', P.C.J. Tooten', J.S. Van der Unde-Sipman', 
T.A. Niewold' 
'Department of Veterinary Pathology, Utrecht University; 3508 TO Utrecht The 
Netherlands;'Felissana Foundation, 3121 XA Schiedam, The Netherlands;"Medica/ 
Center, University of Tenessee, Knoxville, TN 
amyloid findings as recorded in our Department of Pathology's diagnostic center from 1983-1997, and as found in the F€1issana 
Foundation's pedigree database on Abyssinian and Siamese breeds. Amyloid was seen in 70 of 25498 referrals (0.2%). AA-amyloid was 
found in 38 and AIAPP-amyloid in 27 cats. Two cats had an amyloid containing calcifying epithelial odontogenic tumor, two a subcuta­
neous amyloid tumor of the AL-type and another cat had amyloid in a mammary carcinoma. In 1.5% of 710 Siamese and 3.1% of 258 
Abyssinian cat referrals AA-amyloidosis was diagnosed. Cats with AA amyloid (all breeds) were of significantly younger age than animals 
with the other types of amyloid (P<0.0001). The Siamese patients appeared to be familialy interrelated and to descend from three differ­
ent males. Cases from England (mentioned by Godfrey, Vet Rec 1996;139:352) and Sweden (sent in) appeared to belong to the same cat 
families as the Dutch patients. Major gross lesions were liver hemorrhages, enlarged spleen and dilated small intestine. Most Abyssinian 
cases had renal medullary involvement and showed significantly more inbreeding (P<0.002, AN OVA) than the Siamese cats (mean ICs 
calculated for eleven at random chosen cats per category with seven known generations of ancestors were for AbyApos =.1 1 and AbyAneg 
=.08; and for SlamApos =.04 and SiamAneg =.03). For both breeds the differences between the mean ICs for amyloid positive versus 
amyloid negative cats calculated, were not significant. AA-protein amino acid sequences found, revealed slight differences. In comparison 
to the Abyssinian AA-sequence which was similar to those published by others, two non-directly related Siamese ones both had amino 
acid transpositions at pas 46: Q --t R, and pos 52: A -+ V. A domestic shorthair AA-protein Uohnson et al., Camp Biochem Physiol 1989; 
948:765-768) did at pos 30: I -t K, pos 43: D --t E and pos 49: P --t R. The identical amino acid sequences found in both Siamese cats 
indicate a possible more close genetical relationship than could be deduced from their pedigree data sofar. The finding of amino acid sub­
stitutions in the cat indicates the occurrence of different genes for amyloidogenic feline SAAs. An explanation for the higher prevalence 
of amyloidosis in some breeds might be more amyloidogenic SAAs, although other options exist as well. In 25% of the Abyssinian cats 
with amyloid, 36°/o of the Siamese cases and 63% of other breed cats with AA-amyloid inflammatory processes such as rhinitis or feline 
infectious peritonitis which might be considered primary to their reactive amyloid, were encountered. Recent avian in situ hybridization 
findings concerning mRNA for 5AA in amyloid-containing joint capsules (Dvelgonne et al., to be published) were included in the discus­
sion on amyloid and its site of deposition. 
I n my first attempts to conceive and deliver lectures in medical genetics for veterinary students over thirty years ago, I learned early the necessity of using disease examples in relevant species and the importance of pictures. In those days examples in 
domestic species were fev.l, but thanks to cat breeders and some 
astute cat lovers and scientists who were genetically-inclined, a good 
deal was known about coat color inheritance and the population 
genetics of cats. There were even a few chromosome defects and 
monogenic diseases to talk about. I was grateful. Since that time, 
knowledge of the feline genome has increased greatly and the 
Medical Genetics and the Domestic Cat -
A Potpurry of Thoughts, Experiences, and 
Some Genetic Disorders Encountered 
During 30 Years in the Field 
Donald F. Patterson 
Section of Medical Genetics, School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia, PA 
evolving field of veterinary medical genetics has revealed a myriad of feline genetic disorders. Their ever-increasing number is currently 
of major concern to cat owners and breeders. While veterinarians have been responsible for identifying and describing the clinical fea­
tures of most of the genetic disorders presently known in cats and dogs, veterinary medicine as a profession has so far not taken a major 
role in reducing the frequency of genetic diseases in cat and dog populations. The chief reason for this defidency has been the lack of 
education of veterinarians in medical genetics, and the lack of substantial financial support for the research needed to provide basic tools 
for accurate genetic diagnosis, carrier testing and genetic counseling in dinical practice. This is the challenge of the present and the future 
• a dlallenge that applies to all of the animal species in the realm of veterinary medicine. The challenge can be met by veterinary schools 
willing to modernize their curricula, and by agencies that provide funding for education and research in animal health. It is encouraging 
that this conference, one of the first to deal primarily with genetic diseases of the cat, has been so generously supported by Ralston Purina 
and the Winn Foundation. My objective in the remaining portion of this brief presentation is to discuss some intriguing aspects of cat 
genetics and genetic diseases not dealt with by other speakers at this conference. Included will be a number of unpublished and pub­
lished personal observations, drawing in part on the many collaborations I have enjoyed with fellow scientists who also are fascinated by 
the physical anO behavioral beauties of the cat and by the things cats can teach us about genetics and genetic diseases. 
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Fel ine Hereditary Diseases: An 
Overview W'th the control of most infectious diseases, nutritional imbalances, and intox­Ications, hereditary disorders have surfaced as a major problem in feline med­tcine. Currently, over 150 hereditary disorders have been documented in 
Urs Giger 
purebred and domestic shorthair/longhair cats; many of them are identical to 
the ones described in dogs and humans. lhey represent a large and growing, heteroge­
Section of Medical Genetics, School of Veterinary Medicine, 
University of Pennsylvania, Philadelphia, PA 
neous group of disorders which may affect any organ system and include congenital mal­
formations, inborn errors of metabolism, specific organ dysfunctions, and susceptibilities 
to infectious, immune-mediated processes, and cancer. Data bases covering all feline 
hereditary disorders are being developed and many diseases are being discussed during 
this conference. 
Most reported disorders in cats represent single gene defects and are inherited by an autosomal recessive trait. Diseased cats have two 
mutant (abnormal) genes (alleles) and are generally the offspring of clinically asymptomatic parents who carry a mutant and a normal allele 
known as carriers. Affected cats may have littermates that are also affected, are carriers, or are clear of a mutant allele. Certain inbreeding 
practices have led to an increased frequency of specific genetic defects in various breeds. Furthermore, examples of x·linked recessive traits 
are hemophilias and muscular dystrophy; polydactyly and polycystic kidney disease are autosomal dominant traits. Hip dysplasia, patellar 
luxation, and congenital heart defects may be complex or polygenic disorders. 
Much progress has been made in the characterization of the underlying genetic defect, such as enzyme deficiencies and alterations in 
many other protein functions or expressions (receptors, transporters, and plasma proteins). lhe major advancement of the human genome 
project led recently to the first establishment of a feline gene map. This feline gene map will enable the discovery of mutations in novel genes 
responsible for other genetic diseases. 
Clinical manifestations are extremely variable ranging from benign to debilitating, but are usually chronic and progressive. Beside routine 
clinical investigations, special biochemical or molecular screening tests are now available to reach a specific diagnosis of many inherited dis· 
orders. Some of these tests are not only useful to identity affected animals, but also to detect carriers (asymptomatic). Molecular genetic tests 
have simple sample submission requirements and are most accurate to determine affecteds, carriers, and normals. lhus, these tests togeth· 
er with appropriate genetic counseling provide avenues to eliminate mutant genes from the breeding pool, while preserving desirable traits. 
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I ]e fading kltten syndrome is dlaracterized by anorexia, lethargy, and emaciation 
nd is part of the kltten mortality oomplex which refers to a high incidence of neona­
al mortality, birth defects, and reproductive failure in cats. Kittens may be stillborn, 
r born small, weak, and unable to nurse, resulting in dehydration, hypothennia, 
hypoglycemia, and death within the first few days of life. Other klttens appear healthy dur­
ing the first weeks of life, become weak and anorectic, and die of starvation and dehydra­
tion. Underlying causes of neonatal kitten deaths Include poor management, malnutrition, 
congenital and genetic defects, infections, and neonatal isoerythrolysis. Preweaning mor­
The Fading Kitten Syndrome 
and Neonatal lsoerythrolysls 
Margret L. Casal, Urs Giger, Mark E. Haskins 
Section of Medical Genetics, School of Veterinary Medicine, 
University of Pennsylvania, Philadelphia, PA 
tality rates between 14 and 23% have been found with peak deaths occurring at birth and at 6-7 weeks of age. Often the cause of death 
cannot be detennined, but inbreeding may result in homozygosity of deleterious genes leading to lethal structural and metabolic defects. 
Neonatal isoerythtrolysis is caused by an incompatibility of the kltten's blood type with the queen's colostrum. cats with blood group A 
have antibodies in their blood and colostrum against blood group B, but the levels of these antibodies are relatively low. However, cats with 
blood group B have very high levels of antibodies against type A in their blood, and most importantly in the colostrum. When kittens with 
blood group A are born to a queen with blood group B, they ingest milk containing antibodies against their own blood group. This leads to 
destruction of the kitten's red blood cells. The signS of disease are variable and include jaundice and death within the first two days of life, 
no signs at all (which is rare) or the tail tip may become necrotic and fall off at 10 to 14 days of life. �cent advances in mammalian genetics offer us the opportunity to develop the 
next generation· of genetics tests. These tests, which are often referred to as DNA­
ased genetic tests, are particularly important for genetic diseases that are inherit­
d in an autosomal recessiVe fashion. Diseases showing this mode of inheritance 
are partiallarty problematic because animals that only carry one copy of a defective gene 
do not show signs of the disease, yet they pass their defectiVe gene to 1/2 of their offspring, 
on average. Genetic tests that are based on DNA analysis can discriminate between nonnal 
appearing animals that carry one copy of the mutant gene (carriers) and nonnal animals 
that don't carry the defective gene (nonnal, both copies of the gene are nonnal and func­
tional). 
Molecular Genetic Tests: How 
Do These Tests Work? 
Paula Henthorn 
Section of Medical Genetics, School of Veterinary Medicine, 
University of Pennsylvania, Philadelphia, PA 
DNA-based genetic tests detect differences in the DNA sequence. DNA is composed of four different types of bases, or building blocks, 
abbreviated as A, C, G, and T, that are arranged like beads on a string. These bases encode all of the proteins in an animal's body, and each 
cell contains a complete copy of the animal's DNA, often referred to as the genome. The genome of any mammal is thought to contain 6 
trillion base-pairs of DNA If one thinks of the DNA of a single cell as four colors of glass seed beads on a string, it wouJd take two strands 
of beads over 3000 miles long to represent an entire mammalian genome. Even more remarkable is that fact that the substitution, deletion, 
or addition of a single bead or base-pair can cause a lethal disease. Current technologies allow us to detect these minute, but sometimes 
life-threatening differences. 
How are these tests done? The most time- and cost-consuming part of a DNA-based genetic test involves isolating a particular piece of 
DNA, sudl as a gene, that is associated with the genetic disease. This must be done from both nonnal and disease-affected animals, so that 
the DNA difference or mutation associated with the disease can be Identified. Depending on what is known about a particular genetic dis­
ease ln other species, in particular, in people, this process can take as little as a few months, to decades. The intense effort to isolate and 
sequence the human genome will be enonnously helpful in the study of animal genetic diseases. The relatively small number of currently 
available genetic tests ln cats and dogs attests to the effort necessary to develop these tests. 
Once developed, DNA-based genetic tests can be perfonned shortly after birth using DNA isolated from various tissue sources. A drop of 
blood, hair follicles, or cheek swabs are all common sources of DNA and are obtained by relatively non-invasive tedlniques. The polymerase 
chain reaction (PCR), Is invariably used to amplify selected DNA segments up to billion-folds so they can be examined. The DNA fragments 
are then examined in various ways, including DNA sequencing and various electrophoretic tedlniques, that detect the DNA change that caus­
es or is associated with the particular genetic disease. These data are the diagnostic infonnation that indicate if an animal is nonnal, a car­
rier, or Is affected with the genetic disease. Once identified, carrier animals can still be bred, but only to nonnal animals, thus avoiding the 
production of any animals that will be affected with the disease. Furthennore, if the breeding of carrier animals is minimized, the disease­
causing version of the gene eventually can be eliminated from a population. Clearly, an important component of genetic testing is the analy­
sis of the test results in the context of the entire pedigree and the particular breed in general. 
DNA� genetic tests are currently available only for diseases caused by defects in single genes. As the day progresses, you will hear 
about DNA-based testsJor specific genetic diseases and how the feline genome project will allow scientists to develop tests for those genet­
Ic diseases for whidl we don't yet know which gene is affected and for diseases caused by defects in multiple genes. 
Heritable coagulation disorders in cats are caused by deficiency or dysfunction of specific clotting fac­tors. Ootting factors are proteins that function as enzymes, coenzymes, or substrate in the process of coagulation that culminates in fibrin clot fonnation. Deficiency of any single clotting factor caus­es prolongation of in vitro clotting time, and In vivo bleeding diatheses of variable severity. Specific 
ease phenotypes are diagnosed on the basis of in vitro functional tests (coagulant activity assays). In gen-
1!ral, In vitro factor activity is predictive of clinical severity. Unfortunately, delay in diagnosis is common, and 
� cats  experience repeated episodes of bleeding before definitive diagnosis. 
of the heritable factor defects found in human beings have been described in cats. The most com­
these Include hemophilia A (factor VII I deficiency), hemophilia B (factor IX deficiency), factor Xll defi-
Fel ine Hereditary 
Coagu topathies 
Marjory B. Brooks 
Comparative Coagulation Section, 
Diagnostic Laboratory, Cornell 
University, Ithaca, NY 
and dysfibrlnogenemia. These defects have been identified in different breeds including Siamese, Persian, British shorthair, Havana 
and In many unrelated DSH/DLH families. Factor XII defiCiency is unusual because prolongation of clotting time is an in vitro phe-
Con tinued on page 20 > 
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nomenon, with no associated clinical bleeding disorder. Uncommon defects, identified in only a single breed or line, Include factor VII defi­
ciency and factor X deficiency In DSH cats, and deficiency of vitamin K-dependent factors In Devon Rex. 
Hemophilia A and B are X·linked recessive traits, whereas the expression pattern of other factor deficiencies appears to be autosomal 
recessive. The common hereditary coagulopathies seem to arise from de novo mutations and are usually propagated when asymptomaflc 
carriers are bred. The molecular genetic defects responsible for various disease phenotypes have not yet been Identified in cats. In human 
beings, hemophilia A and B, and dysfibrinogenemia are molecularly heterogeneous disorders, with many different mutations identified In 
different unrelated families. Molecular genetic analyses of feline coagulopathles and dotting factor genes will prove whether similar muta­
tion mechanisms occur in the homologous feline genes. Characterization of the feline genes may also prove useful In Identifying mar1ter loci 
for gene mapping studies and for developing clinical assays to enhance detection of heterozygous disease carriers. 
The Feline Genome Project: The 
Role of the Genetic Map of the Cat in 
Fancy Cat Breeding 
genetic linkage map is being developed for the domestic cat 0/er 500 
markers of different types are being mapped In a feline ooss-species 
hybrid between the domestic cat, Fells catus, and the Asian leopard cat, 
rionailurus bengalensis. The feline hybrids are known as Bengals and 
they were produced by both natural and assisted reproduction techniques. A 
majority of the cats used in this family were supplied by Bengal cat breeders In 
the United States. There are over 70 second generation Bengals in the pedigree, 
which will ensure a genetic map that can determine marker associations at far 
genetic distances with high confidence. over 350 of the markers used in the 
project are also being mapped in most fNerY other species' genome project. 
l.ellle A. Lyons, Marilyn M. Raymond, Stephen J. O'Brien 
LJiboialoly d Genomic Diversity. Frederick Cancer Research and 
llfwelopment Center, National Cancer Institute, Frederick, MD 
This will help transfer genetic information about diseases aooss different 
species, transferring information from mouse to humans to cats to dogs or any other species. The remaining markers will be useful for pop­
ulation studies, such as determining gene pool diversity, individual identification, parentage testing and forensic analyses. The genetic map 
identifies which markers are independent, which is necessary for their effective use in population studies. The feline genetic map will facili­
tate the identification of disease genes such as; polycystic kidney disease, progressive retinal atrophies, spasticity, and congenital head 
defects, and phenotypic homologs, such as dwarfism, coat colors and fur types, found In cats and other mammals. We will review hOw the 
genetic map facilitates gene mapping and population studies in the cat, how breeders can assist with the development of the map and dis­
ease gene hunting projects in their cats of interest and how to facilitate interactions between breeders, veterinarians and scientists. 
Heritable Characteristics and Natural 
History of Hypertrophic 
Cardiomyopathy In Maine Coon Cats 
Rllowing the identification of a proband, a rolony of Maine coon cats with a heritable form of hypertrophic cardiomyopathy (HCM) was �1-ped. Selective breedings and periodic echocardiographlc examinations were performed to study the phenotypic expression, natural history, and 
heritable characteristics of the disease. Phenotypically, the disease is charac· 
terized primarily by marked papillary musde hypertrophy, progressive left atrl· 
al enlargement in cats with severe disease, and systolic anterior motion of the 
mitral valve. Approximately half (12122) the offspring produced by mating 
Maine coon cats from the colony with HCM (affected) to Maine coon cats from 
the colony without HCM (unaffected) developed HCM. Breeding affected to 
affected colony cats produced unaffected cats (n=2), affected cats (n=4), and 
stillborn kittens (n=3). One unaffected to unaffected breeding produced two 
Mark D. Kltllelon, 1 Kathryn M. Meurs,' Judith A. KitUeson, 1 Marcia 
Munro,• SI-Kwang Uu,' Jeffrey A. Towbin' 
'Unftlenlity of California, Davis, CA;• The Ohio State University, 
Columbus, OH;' East Haven, CT; • The Animal Medical Center, New 
)brt{ City, NY; •Baylor College of Medicine, Houston, TX 
unaffected cats. Equal numbers of males and females were affected. 
Whenever, an affected cat was bred to another cat, at least one affected cat was produced. Males and females both transmitted the disease. 
Multiple instances of male to male transmission were identified. This pattern is compatible with an autosomal dominant trait with 100% pen­
etrance in which the stillborn kittens represent lethal homozygotes. In cats from affected to unaffected matings, HCM was not evident before 
one year of age, usually became apparent by two years of age, and usually progressed to severe disease by young adulthood (2 to 4 years 
of age). Males in this group developed more severe disease. In cats from affected to affected matings, HCM became apparent as earty as 3 
months of age and progressed to severe disease between 6 and 18 months of age. Males and females in this group both developed severe 
disease. Cats with severe disease died suddenly (n=4) or of heart failure (n=3). Five of the seven cats that died were males. At postmortem 
examination, each severely affected cat had moderate to marked myocardial fiber disarray, intramural coronary arteriosclerosis, and Inter· 
stitial fibrosis. We conclude that HCM in Maine coon cats closely mimics human familial HCM In which sarcomeric gene mutations are respon­
sible for the disease. It most closely mimics the disease observed in human families that have light chain mutations. 
Strategies to Avoid Detrimental 
Breed Characteristics 
Joan MUter 
The Wlnn Feline Foundation 
I 
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Acat breed is a distinctive group of cats that is genetically Isolated In some way. The very concept of breed development, Improvement, refinement or preser· vation lnwlves controlling inherited traits through reproductiVe selection. Vet when strictly considering sound health it is generally believed that animals 
with random genetic diversity will be superior. This contradiction Is an interesting chal­
lenge for breeders and their veterinarians. Isolated populations of domestic cats, 
whether confined to islands or farm colonies, do seem to thrive in spite of a high 
degree of natural inbreeding. The intervention of cat breeders In reproductive selec· 
tion is also not necessarily detrimental when there is awareness and plamlng. The •cat 
Continued from page 20 -
fancy' exists to enhance and preserve natural or established historical appearance, desirable genetic mutations and unique breed personal· 
ity characteristics. We need to develop better strategies to achieve these goals while avoiding heritable disorders and loss of general vigor. 
Some of the healthiest breeds have extremely small gene pools. Many of the breeds have a relatively static genetic makeup that has exist­
ed for over a century without serious problems. In the majority of breeds it is now impossible to find two cats unrelated to each other because 
every pedigree is based on a few early founding cats. Methods used to achieve consistent conformation are inbreeding, linebreeding, back­
crossing to a superior prepotent male and outcrossing within or outside the breed. These same techniques can have both advantages and 
risks when planning a breeding program emphasizing sound health. As an example, breeders will sometimes start with cats of diverse back­
ground, then inbreed (siblings or father-daughter) to fiX certain qualities and determine undesirable recessive genes, both for conformation 
or health. careful linebreeding (cousin matings or moderate inbreeding) will allow slow development of features without causing general loss 
of vigor. Backcmssing to a superior prepotent male cat can greatly enhance appearance. If the male is a known producer of sound long-lived 
cats he can also benefit the health of a breed. 
Unlike the cattle business keeping progeny records including detailed health/death information is not yet practiced in the cat fancy beyond 
informal word of mouth exchange of wisdom and experience. Knowledge of heritable diseases/disorders in cats is dramatically increasing 
but the sharing of information and taking action to deal with problems is slow. When a specific disorder is recognized in a breed strategy 
must differ. In the Scottish Fold the potential for joint disease/skeletal lesions requires avoidance through the use of outcross breeds approved 
by CFA. The Manx breed, with its mutant tailless feature that must have originated centuries ago, continues to be viable in spite of the in 
utero loss of homozygous kittens. According to CFA registration records Manx litter size is comparable to most other breeds. This is due to 
selection for reproductive superiority in females. Abnormalities thought to be related to the tailless gene have been avoided by breeders who 
are rigorous in their selection of sound cats. A disease such as familial renal amyloidosis in the Abyssinian and related breeds is a special 
challenge. The mode of inheritance is not entirely known, early diagnosis is not possible without a reliable test and affected cats often die 
at an older age after producing litters. Pedigree analysis has become second nature to experienced breeders along with the increased use of 
10 year and older stud cats and cats with minimal inflammatory problems. In the case of polycystic kidney disease in Persian cats testing 
clinics are being established to help Identify affected cats prior to breeding. The CFA Health Committee, The Winn Feline Foundation, a men­
taring program for new breeders, breed standards that allow for conformation variability and strider penalties for unsound features, show 
rules that prohibit surgical correction, are examples of the ways in which the cat Fanciers' Association is helping to improve the genetic health 
of pedigreed cats. 
11e Abyssinian cat has been shown to be affected by a hereditary retinal 
egeneration that shares many similarities with human retinitis pigmentosa 
RP). The disease was characterized by clinical and laboratory investigations in 
groups of normal cats and Abyssinian cats affected by ophthalmoscopically 
obvious disease. In short, the fundus appeared normal until the animals reached 
young adulthood, at the age of 1.5· 2 years, at which time slowly progressive changes 
began, that led to generalized retinal atrophy by the time the cats were middle-aged. 
DC -electroretinography (ERG) showed that there was a primary effect by the disease 
on the function of rod photoreceptors with a later involvement also of the cone sys­
tem. The function of the retinal pigment epithelium (RPE) was not affected, however, 
Progressive Retinal Atrophy in 
Abyssinians 
Kristina Narfstrom 
Department of Surgery and Medicine, Faculty of Veterlnaty 
Medicine, Swedish University of Agricultural Sciences, 750 
07 Uppsala, Sweden 
until at a late stage of the degenerative disease process. These changes were verified by ultrastructural studies which showed changes 
primarily in solitary rod outer segments or in several rods in patches, while cones and other retinal cells were normal appearing. The 
morphological changes were more severe in midperipheral and peripheral areas of the retina compared to the central parts, which 
seemed to be spared until late in the disease, when there was a generalized drop-out of both rods and cone photoreceptors. Through 
retrospective studies of breeding pairs and their off-spring a simple recessive mode of inheritance for the defect was found. 
During the last decade this rod cone degenerative disease has been further studied in order to more thoroughly characterize the 
disorder as to early functional and morphological changes, including the use of immunohistochemical and immunochemical meth­
ods. Biochemical studies of blood and affected tissue have also been performed as well as, more recently, specific physiologic and 
molecular genetic studies. Candidate gene analysis of genes encoding for proteins and enzyme systems mainly of the photorecep­
tor transduction cascade has so far not led to the elucidation of the genetic defect. During recent years also treatment trials have 
been initiated, utilizing the technique of neuro·retinal transplantation. 
It is clear that this Abyssinian cat mutant now is a well characterized animal model for RP, which offers the advantage of a large 
eye with several similarities to the human eye. Routine ophthalmic examinations can be performed in cat as well as the utilization 
of medical and surgical techniques regularly in use fur human patients. Furthermore, the cat has since long been an established 
spedes in the field of basic and applied Neuroscience, which so far has rendered a great amount of basic scientific knowledge espe­
cially in the fields of Neurology and Ophthalmology. It is therefore of great importance that research into the Abyssinian cat degen· 
eration be further pursued. Investigations of priority include: 
•To elucidate the gene defect in rdAc 
•To persue the issue of retinal transplantation with focus on structure and function. 
•To investigate the cone mechanisms in hereditary rod-cone degeneration 
•To study the physiology of ocular circulation in retinal heredo·degeneration. 
Still another hereditary retinal disease exists in the Abyssinian cat. In England a dominantly inherited rod cone dysplasia has been 
described. Affected cats are congenitally visually impaired, some have nystagmus and blindness is obvious at the age of 1 2· 16 
weeks. Morphologically the rods and cones never develop normally in this Abyssinian cat mutant. The genetic defect has not been 
found. 
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Lysosomal Storage Diseases in Cats: 
LJsosomes are small structures located inside cells which function to 
degrade and recycle many large compounds (substrates) In the 
body. The molecules responsible for dismantling the substrates are An Overview 
Mark E. Haskins series of about 40 enzymes. • 
A lysosomal storage disease results from a mutation In the genetic code 
for one of the 40 enzymes. Most of these diseases are inherited as auto­
somal recessive traits. Because of a mutation, an enzyme fails to degrade 
School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 
I 
its substrate. This failure in degradation results in the accumulation (stor· 
age) within lysosomes of the substrate of that enzyme, hence the name lysosomal storage disease. The name of each disease usually refers 
to the substrate which is stored. The first definitive discovery of a lysosomal storage disease in a cat was GM 1 gangliosidosis in a Siamese 
cat by Baker et al. in 1971. Nine additional diseases have now been described In cats: GM2 gangliosidosis, glycogen storage disease II, alpha 
mannosidosis, mucopolysaccharidosis I, VI, and VII, globoid cell leukodystrophy, Niemann Pick disease type C, and mucolipidosis 11. 
Cats with lysosomal storage diseases frequently have central nervous system problems with head tremors and abnormalities in gait Some 
also have cloudy corneas, and abnormalities in bone development with short legs, small ears, and a flat face. Many of the diseases result in 
severe disability and death within the first year of life, while others are less severe with life spans extending up to 8 years. 
There are no uniformly successful approaches to treat lysosomal storage diseases. Preventing mating of cats which cany a mutation can 
result in the eradication of a lysosomal storage disease from an individual family of cats, while retaining the desirable characteristics of the 
line. The diagnosis of carriers for these diseases is becoming increasingly more accurate with the availability of molecular techniques which 
have been developed after the gene for the enzyme has been cloned. Enzyme assays on blood or cells grown from skin biopsies are help­
ful in those diseases or families where the mutation has not been identified. 
Current research to develop approaches to therapy include 1 )  injection of normal enzyme, 2) bone marrow transplantation, usually from 
a sibling, and 3) gene therapy, where a copy of the normal gene is put into an animal's own cells. 
Molecular Screening for the Feline 
Gangliosidoses in Korats 
11e gangliosidoses are inherited diseases affecting several cat breeds, 
most notably Korats. Although neurological diseases resembling the 
gangliosidoses have been observed in Korats since the 1960s, the first 
ocumented report of GM2 gangliosidosis in Korats was published in 
1985, and this year castagnaro et al described the first confirmed case of GM1 
gangliosidosis in Karats. The occurrence of two entirely different mutations in a 
single breed, which result in diseases with very similar clinical and pathological 
characteristics, is remarkable and seriously complicates diagnoses and epl· 
demiological studies. Because the gangliosidoses are inherited as autosomal 
recessive traits, the periodic appearance of these diseases over four decades 
Henry J. Baker, DVM', Bruce F. Smith, VMD, PhD', Douglas R. Martin, 
PhD', Polly Foureman, PhD', Massimo Castagnaro, DVM, Ph!Y 
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may represent an ominous presence of many carriers of these mutations in the 
breed. A breed wide screening program is the only valid approach to accurately estimate the incidence of these mutations and eliminate car· 
riers from breeding stock. Although these diseases can be diagnosed by enzyme assays, there is sufficient overlap between carrier and nor· 
mal biochemical phenotypes that indeterminant results are frequent, complicating use of these enzyme results for breeder selection. 
Therefore, unambiguous molecular testing is critically important to detect carriers and encourage breeder participation. Muldoon, et al 
described the mutation responsible for Korat GM2 gangliosidosis in 1994. Recently, we described the sequence of the normal feline �-galac· 
tosidase gene, discovered the mutation responsible for GM1 gangliosidosis in Siamese and discovered the mutation responsible for GM2 
gangliosidosis in nonpurebred cats. Our studies demonstrate that the GM2 mutations of Korat and nonpurebred cats are different and we 
have shown that the same mutation is responsible for GM 1 gangliosidosis in both Siamese and Korats. These discoveries provide an unprece­
dented opportunity to apply molecular diagnoses for carrier detection. An international program to screen Korats for the gangliosidosis muta­
tions has been organized and testing is currently in progress. To date, 69 samples from Korats located in 6 countries have been received for 
testing. Carriers for both GM 1 and GM2 gangliosidoses have been detected in these submissions. 
Coat Genetics in Domestic Cats 
Heather E. Lorimer 
Department of Biological Sciences, Youngstown State University, 
Youngstown, OH 
rtificial selection by humans has resulted in preservation and prolifer· 
tion of a large variety of coat colors, length, and texture, in the 
omestic cat Currently approximately 15 genes, each with two or 
ore alleles, cause easily observable differences. In additional, there 
are polygenetic 
factors that affect coat color. 
Color and coat genes encompass a wide variety of modes of inheritance. 
These include the familiar sex-linked orange/red color which produces text­
book mosaicism in heterozygous females, as well as simple dominant/reces­
sive alleles such as the dilute gene which affects pigment deposition in the 
cells of the hair shaft, easily visible under low power magnification of individual hairs. Other color genes are pleiotropic, causing a number 
of effects besides color. The temperature sensitive allele of the albino gene causing pointed color in many cats including Siamese, effects the 
optic nerve pathways. Dominant white is pleiotropic, epistatic, and has variable expression. White color apparently results from altered devel· 
opment, particularly programmed cell death, and occasionally causes deafness through hair cell degeneration in the inner ear after birth. The 
rex genes cause similar phenotypes of curly coats through 
different genes. Tabby patterns were thought to be created by several alleles of one gene. Data collected from the cat fancy indicates that 
tabby patterns are probably caused by at least three separate genes with multiple alleles. 
When the genes that are involved in coat color are located on the feline chromosomes they will provide genetic markers whose linkage 
to other genes should be easy to observe and thus they should contribute markedly to the feline genome project. 
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Cnine hip dysplasia (HD) and patellar luxation (PL) are common, well-recognized orthopaedic conditions. They are considered sep­rate disease entities and are thought to occur infrequently in the arne dog. Hip dysplasia is particularly prevalent in large and 
giant breed dogs, whereas PL is commonly found in toy and miniature 
breed dogs. In contrast, HD in cats presents clinically less frequently and 
it is not common to test cats radiographically or clinically for HD. 
Therefore, feline HD is, less well characterized. Patellar luxation has rarely 
been reported in cats and isolated cases have been thought to be trau­
matic or congenital with little genetic component. A few limited surveys 
have found a higher prevalence of medial patellar luxation in Abyssinian 
and Devon Rex cats suggesting a hereditary basis. The objectives of our 
Patellar Luxation & Hip Dysplasia in a 
Group of Cats 
Gall K. Smith, Anke Langenbach, Urs Giger, Pamela Green, Harker 
Rhodes, Thomas P. Gregor 
· 
Department of Clinical Studies, School of Veterinary Medicine, University 
of Pennsylvania, Philadelphia, PA 
study were to examine the occurrence of hip dysplasia (HD) and patellar luxation (PL) in cats, to determine whether an 
association exists between these 2 orthopaedic conditions, and to relate degenerative joint disease and laxity in a group 
of cats by the use of NA, Dl and OFA scoring. 
A non-random population of 78 cats were examined for the existence of PL and HD. Complete history was obtained, 
physical examination was performed and radiographs of the stifles and hips were made under sedation. The hip-extend­
ed radiographs were evaluated by a board-certified radiologist using the standard 7-point scoring scheme established for 
dogs by the Orthopedic Foundation for Animals (OFA). Evidence of DJD was recorded. Joint laxity was quantitated from the 
hip-extended radiograph using the Norberg Angle method and from the distraction radiograph using the distraction index 
(DI). The relationship of hip DJD to objective hip score was examined. There were 43 males and 35 females with a mean 
age of 2.5 years. Eleven of the 78 cats had cliniccll signs of pelvic limb disease . Hyperlaxity of the patella -subluxation sub­
grade 1- was seen in 31 of 33 cats otherwise diagnosed as normal in the stifle joints. Medial patellar luxation (MPL) was 
found in 45/78 (58%) of the cats. Seventy-one percent (32145) of the cats with MPL had bilateral involvement. Cats main­
ly had Grade 1 MPL. Of the breeds represented Abyssinians and Devon Rex cats were affected with MPL more frequently 
and more severely. Concurrent MPL and HD was seen in 19/78 cats (24%), and an association existed between MPL and 
HD (�.25; p=0.045). Cats with MPL were 3 times more likely to have HD than those without. 
Hip dysplasia was diagnosed radiographically in 25/78 (32%) using the OFA scoring system. Nineteen cats had mild, 4 
moderate, 2 severe HD. Eighteen of the 25 cats with HD had bilateral disease. Fifteen of the 25 cats had DJD. Mean NA in 
the 78 cats was 92.4'(range 56-105'). The mean NA in cats with DJD was significantly lower (84 ') than in cats without DJD 
(95'). No cat had a NA greater than 105'. The mean Dl for all cats was 0.51 (range 0.2-0.84). The mean Dl for cats with 
DJD was significantly higher (0.6) than without DJD (0.49). No cat with a Dl less than 0.4 had DJD. The chance of having 
DJD increased with increasing Dl and decreasing NA and with a worse OFA score. 
Patellar luxation and HD may occur in cats more frequently than reported. The two conditions were observed to occur 
simultaneously in several cats (24%) and a weak association was found between PL and HD. Clinical signs were general­
ly mild, and none were observed with grade 1 medial PL or mild hip dysplasia. Cats in this small sample had hip laxity 
comparable to that observed in breeds of dogs having high indidence of HD, such as Golden Retrievers and Rottweilers. As 
in the dog. there was a positive relationship in the cat between hip laxity and the expression of DJD. 
Domestic cats are commonly affected by bacterial, viral, protozoal, and other infectious agents, particularly in multiple-cat settings such as shelters, catteries, and feral cat colonies. To the extent that susceptibility has a genetic component, the problem has been 
exacerbated in catteries where cat breeding populations may be small, mat­
ing may be strictly regulated, and artificial selection may be intense, lead­
ing to small effective population sizes (NJ. In cats it is difficult to evaluate 
the heritability of susceptibility to infectious disease for two reasons. 
Infectious disease susceptibility may appear in obscure patterns on pedi­
grees In part due to reduced penetrance because of uneven exposure 
among cats to the infectious agents. Secondly, selection experiments to 
determine the heritability to infection in cats have not been performed. 
The Heritability of Susceptibility to 
Infectious Disease i n  Domestic 
Cats 
Janet E. Foley 
School of Veterinary Medicine, Center for Companion Animal Haalth, 
University of California, Davis, Davis, CA 
Whether or not the heritability is precisely known, it would be possible to reduce the incidence of infectious diseases in 
cats by artificial selection. Artificial selection is commonly applied to characters of conformation in cats, but rarely for 
resistance to infection. The current presentation discusses parallel studies in mice and other animal models and the lim­
Ited data available for feline susceptibility to infectious disease. The feline enteric coronavirus model system is described 
In detail as an example of the approach to the study of feline genetics and infectious disease. Approaches are suggest­
ed that might enable us to estimate the heritability of susceptibil ity to infectious disease and evaluate the success of 
selection regimes for increasing resistance. 
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Autosomal Dominant Polycystic 
Kidney Disease in Persian Cats 
Spontaneous ADPKD in Persian cats closely resembles the human 
disease. In cats with ADPKD, renal function gradually deterioraties 
leading to endstage renal disease by 3·10 years of age. Diagnosis 
was based on ultrasonography, gross and microscopic renal 
pathology, or both. Results of Chi square analysis were compatible with 
autosomal dominant inheritance. Renal cystS were lined by cuboidal or 
squamous epithelium and chronic tubulointerstitial nephritis was present 
in most affected cats. Biliary hyperplasia and fibrosis were observed in the 
livers of many affected cats. Na•-K• ATPase immunohistochemistry 
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showed strong basilar staining of thick ascending limbs and distal tubules 
and weak basilar staining of proximal tubules. Less than half of the cysts 
stained for Na•-K• ATPase. Staining with peanut agglutinin suggested that cysts were derived from both proximal and distal 
nephron segments. 
Primers designed from exons 36 and 37 of human PKD1 were amplified in domestic cat DNA generating a 200 bp prod· 
uct. Coding regions are conserved bearing 86% homology between cat and human sequences. The intronic region is 66% 
conserved between the two species. A sequence polymorphism between domestic and leopard cat, identified in the intronic 
region, was genotyped in a 1 10 member interspecies pedigree using single stranded conformational polymorphism. 
Approximately 250 polymorphic microsatellites have been genotyped and are currently in linkage analysis. One dinucleotide 
repeat locus, FCA476 was identified which is linked to feline PKD1 at 10cm with a LOD of 4.0. The locus is moderately het· 
erozygous exhibiting an average heterozygosity in a sample of outbred domestic cats of 0.64. FCA476 will be genotyped in 
the Ohio State Persian cat pedigree and examined for l inkage to a putative disease locus. The pedigree also will be gena­
typed and examined for linkage to a putative disease locus with an additional 25 microsatellites mapped to cat 81 which 
has conserved synteny with human chromosome 4, the location of PKD2. 
Development Strategies for DNA­
Based Tests for Cat Parentage 
Verification 
Aparentage testing system that meets the needs of cat breeders and their registration authorities is likely to be similar to ones suc­
cessfully used for DNA-based parentage tests of horses and other 
domestic animals. Among the variety of available DNA technolo­
gies, currently only short tandem repeats (microsatellites) have proven to 
Ann T. Bowling have the spectrum of genetic properties needed for large-scale animal 
Veterill81}1 Genetics Laboratory, School of Veterinary Medicine, 
University of California, Davis, CA 
parentage verification programs. A microsatellite is a DNA segment char· 
acterized by simple repeat motifs. The efficacy of a microsatellite-based 
test to detect incorrect parentage should be very high-calculated to 
achieve efficacies of 99.99% or greater. The test can be performed using 
a variety of biological samples including blood or hair, but the routine cat 
test will probably use mouth swab samples. With the availability of a parentage test, cat breeders may more effectively attain 
their breeding goals through verified pedigrees, and will have access to highly effective tools to sort out paternity questions 
and switched kitten scenarios. The same DNA-based procedures for verification of pedigrees can be used as genetic identifi­
cation tools to provide forensic evidence in legal proceedings. 
A Forensic Case Involving a Cat 
Marilyn M. Raymond, Victor A. David, J. Claiborne Stephens, 
Leslie A. Lyons, and Stephen J. O'Brien 
Laboratory of Genomic Diversity, NCI-FCRDC, Frederick, MD 
APCR-based method of genetic individualization of domestic cats has been developed which has been applied to DNA isolated from a single 
hair of a domestic cat found on a jacket left at a homicide scene and 
the blood of the suspect's pet cat Ten feline S1R loci were selected 
from a subset of 400 dinucleotide (dC.dA)n . (dG.dl)n repeat loci isolated from 
genomic DNA of Felis catus which had been genotyped in a 70 member pedi­
gree to generate a genetic recombination map. The STR loci were unlinked, 
demonstrated Mendelian inheritance, exhibited high heterozygosity and ampli· 
tied with as little as one nanogram of DNA generating strong, clean electrophoretogram profiles. A ·match window' was 
empirically established for each STR locus based on determining the measurement precision of alleles known to be unam­
biguously identical by descent in the three generation pedigree. A genotype survey of two small population groups was per­
formed which demonstrated that the ten loci exhibit expectations consistent with Hardy-Weinberg equilibrium. 
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Geneva: A Case-Based Learning Tool 
for a Lysosomal Storage Disease in a 
Family of Cats 
Mark E. Haskins, Omar Farias-Liovet 
School of Veterinary Medicine, University of Pennsylvania, 
Phi/sdelphia, PA 
of a series of veterinary or human textbooks or journals. 
AMacintosh-based interactive program is available to teach the basics of a lysosomal storage disease present in a family of cats. The program was developed using Macromedia Authorware which permits combining text, pictures, movement, and sound. 
'The learning process requires further reading to come to a definitive 
diagnosis which must be entered before the program will permit the stu· 
dent to progress. This further reading requires the student to be able to 
search databases, and have a library available which contains at least one 
The program presents the history and signalment, and asks for decisions about tests to be performed, gMng the results of those tests 
selected, and illustrating abnormalities by contrasting them to normal values or pictures. The program includes clinical information, pathol­
ogy, genetics, and a small section on therapy. 
Geneva was used in the first year course in Medical Genetics at the University of Pennsylvania in 1998 and received good reviews 
from the students. 
Feline Genetic Disease Information 
System 
Urs Giger, Cart Seybold, Elizabeth Knighton 
Section Medical Genetics, School of Veterinary Medicine, University of 
��n�, Phi��. PA 
tus far, aver 150 hereditary disorders have been reported In 
omestlcated cats and several new genetic diseases are being dis­
overed every year. They occur In many different breeds as well 
s domestic shorthair/longhair cats, and represent a very hetero­
geneous group invoMng every organ system. They include congenital 
malformations, inborn errors of metabolism, and susceptibilities to immune 
disorders, infections, and cancer. Although several review articles summa-
rize various inherited diseases, a comprehensive information source does 
not yet exist We are presently developing a computer-based feline genet­
ic disease information system which contains on every disease a summary, clinical signs and laboratory test abnormalities, pathologic 
findings, diagnostic tests for affecteds and carriers, mode of inheritance, and recommendations for control of the disease. A first version 
of the computer program has been developed and a few hereditary diseases have been entered. Additional information and illustrations 
on hereditary diseases in cats are solicited. 
Genetic Counseling 
Recommendations Should Account 
for the Demographics of the 
Population and the Epidemiology of 
the Defective Genes 
Jerold s. Bell 
School of Veterinary Medicine, Tufts University, North Grafton, MA 
G enetic counseling recommendations are often either, 'Do not breed any affected or carrier cats,' or 'Breed affected and carri· er cats, but only to genetically normal cats: A recommendation to eliminate carriers of a defective gene may result in a signifi· 
cant loss of breed genetic diversity. This could also concentrate previously 
unknown defective genes through a genetic bottleneck. A recommendation 
to breed carriers keeps the gene pool diverse, but does not provide selec­
tive pressure to decrease the frequency of the defective gene. 
Genetic counseling recommendations should account for the character-
istics of the genetic disease being controlled, and the dynamics of the 
breeding population. The character of a genetic disease includes its severity, typical age of onset, mode of inheritance, and genetic spread 
in the population. Genetic diseases that cause death or significant discomfort, should have a high priority. A late age of onset allows genet­
ically affected cats to be bred before becoming clinically affected. PCR-based tests measure the genotype, and can be run at any age, 
before the age of onset. Polygenic disorders and recessive disorders without carrier tests are difficult to control, because carriers of defec­
tive genes cannot be identified. Wrth these disorders, knowledge of the carrier or affected status of the littermates, the parents, and the 
littermates of parents (breadth of pedigree) provides important selection information on the possible genotype of the individual. 
Widespread defective genes are a concern for all breeders. Conversely, a recent mutation may involve only a small portion of the breed· 
ing population. In this case, genetic disease control should be more stringent, to prevent the defective gene(s) from spreading further in 
the gene pool. Due to the non-random nature of cat breeding, the genetic spread of defective genes does not necessarily relate to the 
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frequency of a gene in the population. Most defective genes In a purebred population originated from a single ancestral source. A defec­
tive gene that is rare in the population, but present 'in two distantly related cats, indicates an older and dispersed gene. While infrequent, 
a wide range of the population will need genetic testing and counseling. 
An effective genetic disease control program requires set goals, based on; the breed, the disease, and the genetic tests available. An 
immediate goal is to decrease the incidence of affected cats being born. With an established testing program, the breed can monitor the 
frequency of the defective gene in the population, and work to decrease the percentage of carriers. With reliable carrier tests, carriers with 
desirable traits can be bred to genetically normal cats. Desirable, normal testing offspring should be selected for future breeding stock. By 
not selecting against carrier breeders, you are selecting for a carrier frequency of 50 percent; much higher than most breed averages. The 
proper use of genetic tests is not one that continually multiplies carriers in a breeding program. It should be geared toward producing qual­
ity, genetically normal cats. As more breeders work away from the defective gene(s), the problem for the breed as a whole diminishes. 
T:e development of whole-genome radiation hybrid mapping 
has revolutionized the field of gene mapping. Construction 
nd characterization of human RH panels composed of less 
han 100 clones has allowed high-resolution physical map­
ping intermediate to that of genetic and YAC·based contig maps. The 
main benefit of RH mapping is its ability to integrate both genetic and 
EST-based maps due to the ability to score any non-polymorphic marl<· 
er that differs between the donor cell line and recipient rodent cell line. 
This method holds great promise for the field of comparative 
genomics and the subsequent development of domestic species as 
Development of a Whole Genome 
Radiation Hybrid Panel for Feline Gene 
Mapping 
William J. Murphy, Mary E. Thompson, Leslie A. Lyons, Marilyn Menolti­
Raymond, Victor A. David, Stephen J. O'Brien 
Laboratory of Genomic Diversity, National Cancer Institute, FCRDC, 
Frederick, MD 
model organisms. Construction of RH panels has been completed or are in progress in almost a dozen phylogenetlcally diverse vertebrate 
species, from mice to zebrafish. We describe the development of a 5,000 rad radiation hybrid panel for the domestic cat, Felis catus. The 
impetus for constructing a cat RH panel is twofold. Rrst, the resolution presently available with the domestic caVIeopard cat interspecies 
cross is 5-30 centimorgans. Thus, finer resolution will require a method such as RH mapping. In addition, the RH panel will be essential 
for ordering loci on parts or all of cat chromosomes 02, Fl, and Y, which cannot be accomplished using the interspecies cross. The utili­
ty of this panel is demonstrated by ordering 3D-40 Type I and Type II loci from feline chromosome 84. The specific implications of sex 
chromosome comparative mapping will also be discussed. 
S hart tandem Repeat (STR) loci have proven to be use­ful for parentage and Identity verification in humans and animals. We have isolated and characterized 13 tri· and tetranucleotide repeat loci  within the 
genome of the domestic cat (Felis catus), suitable for use in 
automated identity and parentage testing. OVer 100 mixed 
breed, non-related individuals and 50 to 75 non-related 
purebred Manx, Abyssinian, and Persians have been gena-
typed. All genotyping was performed using 4-color fluores-
Automated Genotype Analysis i n  Felines 
Using Tri- and Tetranucleotide Repeat 
Sequences 
M. K. Hutton, M. M. Joh� 
PE AgGen, Davis, California 
cent technology on an ABI Prism 373 Sequencer. PCR products are fluorescently labeled during PCR using a primer with a dye 
attached to the 5' end. Markers that separate eledrophoretically in a gel lane by size and color can be co-loaded in a single 
lane. Use of the in-lane size standard (350 Rox), In a fourth color, allows for precise size calling and minimizes gel to gel varia­
tion. Genotypes can be automatically determined using Genotyper 2.0 software. PCR products from the 1 3  loci studied can be 
loaded in two lanes, one lane containing products from B loc! (F27, F42, F37, F41, F1 55, F36, F1 63, F85), one lane containing 
products from 5 loci (F164, F75, F62, F95, F 1 1 5). Allele frequencies, PIC, heterozygosity, and power of exclusion values were 
calculated for each marker, and Mendelian segregation was assessed for all loci tested. 
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Bralnstem Auditory-Evoked 
Responses (BAER) for Diagnosis of 
Congenital Deafness in White Cats 
Andrea Fischer, Gisela Kraus 
University of Munich, Munich, Germany 
W hite cats are presented to the University of Munich in increasing numbers for evaluation of hearing with brain· stem auditory evoked responses (BAER) because the guidelines of the largest association of feline breeders in 
Germany (1. Deutscher Edelkatzenzuchtverband) specify according to 
current German law that (1) there is no permission to breed deaf cats, 
(2) hearing needs to be evaluated by BAER in every white cat prior to 
breeding, (3) white cats may not be bred to each other. 
BAER were recorded from 36 normal cats to describe the configuration of the feline BAER and to establish reference ranges 
for peak latencies. cats were anesthetized with propofol. Technical parameters were identical to a protocol used for dogs.1 
BAERs were recorded with platinum needle electrodes from the 'vertex-mastoid position'. The feline BAER consisted of a series 
of 6 to 7 vertex-positive peaks identified as P1 a, P1 b, P2, P3, P4, P5 and P6. Peak latencies at suprathreshold stimulation 
intensities (90 dB SPL) were 0.92 ± 0.03 (P1 a), 1 .26 ± 0.05 (P1 b), 1.72 ± 0.08 (P2), 2.45 ± 0.1 1 (P3), 3.26 ± 0.14 (P4), 4.34 
± 0.23 ms (PS) and 5.1 8 ± 0.04 (P6). Peaks P1 b and P5 were present in 96 % and 84 Ofo of the recordings, respectively, and 
were the first ones to disappear with decreasing stimulus intensities. 64 Ofo of the recordings showed an additional peak P6 
at stimulation intensitiy levels <:: 90 dB SPL 
BAER were then recorded from 27 cats with white haircoat presented for evaluation of hearing either at the owner's own 
request or because required prior to breeding. The otoscopic and neurologic examinations were normal in all cats. BAER were 
bilaterally absent in 8 cats and unilaterally absent in 3 cats. Affected breeds were British Shorthair (2)1 Persian (3), and Maine 
Coon (6). 
These results demonstrate that BAER testing is a useful diagnostic technique for the diagnosis of congenital deafness in 
cats similar to the situation in dogs. There is broad acceptance bj.,the breeders for this type of examination. In cats, congen· 
ital deafness may also occur unilaterally as has been shown in dogs. Further studies are required to determine the true inci­
dence of bilateral and unilateral deafness in white cats and to establish the pattern of inheritance. 
Preliminary Studies Into the Anatomy and 
Biology of the Feline Olfactory Epithelium 
Nancy E. Rawson, Markus Goldman, Shay Hyman, George Gomez 
Monell Chemical Senses Center; Philadelphia, PA 
S tudies of olfactory neurophysiology have progressed rapidly over the last decade in a wide variety of species, ranging from invertebrates such as lobster and drosophila to vertebrates including amphibians, 
fish, rodents and humans. Many basic elements of olfactory 
neurophysiology have been found to be remarkably con­
served across diverse species, but species differences have 
also been found that suggest evolutionary cnanges have 
occurred to optimize function. Remarkably, virtually nothing 
is known of olfactory physiology in any obligate carnivore 
species such as the cat. In addition to being of interest in 
order to fill-in this gap in our knowledge, the olfactory neuron is of interest as a tool to help understand neuronal 
processes occurring elsewhere in the body. Our laboratory has developed a technique to study individual olfactory 
neurons obtained from biopsies from living human subjects. As this tissue is capable of regeneration, biopsies can 
be obtained without permanent damage to the epithelium. If a similar biopsy technique can be developed for use 
with cats, we could study the i mpact of a variety of diseases on neuronal function at the cellular level from live ani­
mals. We have therefore begun structural and functional studies of the olfactory epithelium in young and adult cats 
obtained immediately after sacrifice. Preliminary results include anatomical studies to localize the olfactory epitheli· 
urn within the nasal cavity and characterize the cell types present; molecular biological studies to begin to identify 
feline olfactory-specific genes, and studies using calcium imaging techniques to characterize olfactory neuron tunc· 
tion. 
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E ighteen cases of a syndrome of episodic muscle weakness were identified in Burmese kittens. Oinical signs first became apparent between 2-6 months of age. Ventral neck flexion and limb weakness were the most consistent 
signs. Low potassium levels (<3.5 mmoi!L) were documented in 
16 kittens and CPK levels ranged from 454 to over 100,000 iu/L. 
EMG recordings and muscle biopsies were normal. There was no 
evidence of inadequate intake or excessive loss of potassium and 
the syndrome bears similarities to hypokalaemic periodic paralysis 
Hypokalemic Episodic Weakness in 
Bu rmese Kittens 
Timothy J. Gruffydd-Jones, Andrew H. Sparkes, Sarah A. Caney, Danielle G. 
Gunn-Moore, Christopher P. Sturgess 
The Feline Centre, Department of Clinical Veterinary Science, University of Bristol, 
Langford, Bristol, England 
in man which Is related to a calcium channel disorder. Signs resolved in half the kittens but recurred occasionally associated with 
persistent hypokalaemia in others. A familial relationship between affected cats was identified. 
I ncidence of mediastinal lymphosarcoma In young FeLV·nega­tive pedigreed Oriental Shorthair cats has been observed since the early 1 980's. Affected cats are typically between 3 months and 2 years of age, and present initially with dyspnea or diffi· 
culty in eating. Characteristically further examination reveals a 
large mediastinal mass with metastases to surrounding lymph 
nodes. Tumors grow rapidly and are quickly terminal unless treat-
ed. Tumors regress rapidly in response to chemotherapy and there 
are currently a number of affected cats that have survived for a 
year or more with treatment. 
Hereditary Lymphosarcoma in Oriental 
Shorthair Cats 
Heather E. Lorimer 
Department of Biological Sciences, Youngstown State University, 'ltlungstown, OH 
Pedigree analysis reveals that the vast majority of affected Oriental Shorthair's are descendants, on both their maternal and 
patemal sides, of a single male who died of lymphosarcoma in the early 1980's. A few affected cats have this line of descent 
form only one parent. In spite of those individuals who are not obviously inbred on the propositus, this lymphosarcoma has 
many attributes of a recessive genetic disease: most affected cats trace back to the propositus on both sides, many generations 
of unaffected cats can be the ancestors of an affected litter, usually only approximately 1/4 of the kittens in a litter are affect­
ed, and when a cat that later develops the disease is bred to a relative, much larger percentages of kittens in the litter are 
affected. 
Tlis study is based on a retrospective analysis of 29,545 surgical pathology cases submitted to the Laboratory of Pathology, University of Pennsylvania, School of Veterinary Medicine over a 1 0-year period between 
1986 and 1995. The tumors were classified using the 
International Histologic Classification of Skin Tumors, 
Goldschmidt, MH. et. al. (In press) and Soft Tissue Tumors, 
Hendrick, MJ. et. al. (In press). Odds ratios with 95% confidence 
limits were calculated for all feline breeds at risk for developing 
Skin and Soft Tissue Tumors of the Cat: A 
Retrospective Study and Analysis of Breed 
Risk 
Michael H. Goldschmidt,' Frances S. Shofer,' Jennifer Smelstoys" 
'Department of Pathobiology, 'Department of Clinical Studies, University of 
Pennsylvania, School of Veterinary Medicine, Philadelphia, PA 
skin tumors. Statistical significance (p < 0.05) was determined by the Fisher's exact test. 
Tumors found to have an increased or decreased breed risk include basal cell tumor, squamous cell carcinoma, sebaceous 
adenoma, apocrine carcinoma, anal sac gland carcinoma, ceruminous gland carcinoma, melanocytoma, fibrosarcoma, lipo­
ma, hemangiosarcoma, and mast cell tumors. 
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Medical Data Program was undertaken to 
Congenital Portosystemlc Vascular 
Shunts In Cats: 98 Cases A
etrospedive study using the Veterinary 
dentify cats with portosystemic vascular
. 
hunts. Congenital shunts were confinned in 
98 cats at 17 institutions. lhere were slightly more 
Julie It Levy males (56%) than females. Mixed breed cats accounted 
Co/l8g8 of Veterinary Medicine, University of Florida, Gainesville, FL for 73% of the cases, and 2 related breeds (Persians 
and Himalayans) comprised another 16% of cases. 
Clinical signs attributed to hepatic encephalopathy were 
reported by the owners by 6 months of age In 80% of 
cats, although diagnosis was often delayed. Heart munnurs were ausculted in 130/o of cats, and 18% of males 
were cryptorchid. lhe most common clinical signs were salivation (85%), stunted growth (83%), seizures 
(67%), ataxia (60%), vision deficits (54%), tremors or twitching (48%), and mydriasis (38%). 
RBC microcytosis was present in 36% of cats tested. High ALP (54%) and ALI (24%) and low BUN (46%) 
and creatinine (35%) were the most common biochemical abnonnalities. Urine specific gravity was below 
1.025 in 32% of cats, and 12  cats had a history of ammonium biurate urolithiasis. Uver function testing indi­
cated increased BSP retention (83%), fasting hyperammonemla (97%}, fasting bile acids (87%), and post-pran­
dial bile acids (1 00%). 
lhe most common type of shunt was the single extrahepatic portocaval anomaly. Surgery pertonned in 83 
cases resulted in 31 complete ligations, 40 partial ligations, and 14 perioperative deaths or euthanasias. 
OVerall, clinical condition improved following shunt correction surgery, particularly If a complete ligation was 
achieved. 
Inherited Degenerative Joint Disease in 
Cats due to Mild Mucopolysaccharidosis 
Type VI 
Allison C. Crawley, GouriYogalingam, Viv Muller, John J. Hopwood 
Lysosomal Diseases Research Unit, Department of Chemical Pathology, 
v.wnens and Children's Hospital, North Adelaide, South Australia, 5006 
H 
uman mucopolysaccharidosis type VI (MPS VQ 
is a genetically inherited lysosomal storage 
disease caused by a deficiency of the lysoso­
mal hydrolase N-acetylgalactosamine-4-sulfa-
tase (4S), and leads to lysosomal accumulation of its 
undegraded substrate dennatan sulphate (OS). lhis caus­
es pathology in connective tissues, with severe skeletal 
defonnity and death usually In late childhood. Variability 
in disease severity is observed in human patients due to 
different mutations in the 4S gene. A naturally occurring 
feline model of MPS VI was first described In Siamese cats In Philadelphia (Jezyk et al., Science 198:834-836. 
1977), and has since been described in Longhaired Siamese and domestic cats in many states In the USA and 
in Italy (Haskins et al., JAVMA 182:983-985. 1983; Di Natale et al., JIMD 1 5:17-24. 1992). Disease In MPS VI 
cats is similar to the human disease. A colony derived from the original cats has been established in Adelaide, 
Australia, to develop therapies for MPS VI patients. DNA analysis Identified two disease causing 4S mutations 
within this colony. Cats homozygous for an amino acid substitution (L476P) exhibit severe clinical disease, 
with dwarfism, corneal clouding, degenerative joint disease, very low leukocyte 4S/�·hexosaminidase ratios, 
DSuria, and lysosomal inclusions in leukocyteS and in most connective tissues. Cats homozygous for an 
amino acid substitution (D520N) and compound heterozygote cats (L476P/D520N) have similar biochemical 
features but have nonnal growth, lack corneal clouding, and only have inclusions in leukocytes and some 
chondrocytes. L476P/D520N cats also have a high incidence of degenerative joint disease. We conclude that 
L476P/D520N cats have a very mild MPS VI phenotype distinct from the L476P/L476P phenotype. lhe study 
of L476P/D520N and D520N/D520N genotypes will improve understanding of genotype to phenotype cor-
relations and the pathogenesis of skeletal dysplasia and joint disease in MPS VI. 
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L
ysosomes contain many acid hydrolases that are Involved in 
the stepwise catabolism of several large compounds including 
glycosaminoglycans (GAGs), also known as mucopolysaccha­rides (MPS), other polysaccharides, sphinglipids, 
glycolipids,.and glycoproteins. Deficiency in activity of any one of 
these hydrolases causes substrate accumulation in lysosomes. Most of 
these lysosomal storage diseases (LSD) are inherited as autosomal 
recessive traits, and are associated with progressive neurologic, car-
Lysosomal Enzyme Activities i n  Feline 
Leu kocytes and Plasma 
Ping Wang, Peter Jezyk, Margie WeH, Mark E. Haskins, Donald F. Patterson, Urs 
Giger 
Section of Medical Genetics, School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia, PA 
diovascular, musculoskeletal, hepatic, and/or ophthalmic signs. Thus far, 10 different LSDs have been reported in cats. The metabolic 
screening laboratory at the School of Veterinary Medicine, University of Pennsylvania is an integral part of the NIH-supported Referral 
Center for Animal Models of Human Genetic Disease and has established reliable methods to study many lysosomal enzyme activities, 
essential tools to specifically diagnose cats with LSD. Here we present data on 14 1ysosomal enzyme activities in leukocytes and plasma 
from 30 healthy cats: ;�dd a-galactosidase, acid a-glucosidase, add sphingomyelinase, arylsulfatase A, arylsulfatase B, a·L·fucosidase, 
galactosylceramidase, !}-galactosidase, �-glucosidase, p-g!ucuronidase, j3-hexosaminidase, a-L-iduronidase, a·mannosidase, and j3-man­
nosidase. These data are compared to those in cats with specific enzyme deficiencies studied In this laboratory. The availability of these 
assays not only allows the diagnosis of the specific LSD, but in many cases also offers an opportunity to test for carriers, preventing the 
further spread of these diseases. Anally, these enzyme assays are helpful to assess the effects of gene transfer experiments. 
R
line hemoglobin is particularly susceptible to oxidative 
damage and, thereby, to the formation of methemoglobin 
(Met-Hb) and Heinz body in erythrocytes. NADH-methemo­
globin reductase (EC1.6.2.2; cytochrome b5 reductase; 
NADH diaphorase) is important In the reduction of Met-Hb to axy· 
hemoglobin (Hb). We describe here a family of domestic shorthair 
cats with severe methemoglobinemia. 
One male and one female domestic shorthair kitten were found 
to have dark brown mucous membranes and tongue on physical 
Familial Methemoglobin Reductase 
Deficiency in Domestic Shorthalr Cats 
U. Giger,' P. Wang,' M. Boyden' 
'Section of Medical Genetics, School of Veterinary Medicine, Uflitlelsity of 
Pennsylvania, Philadelphia, PA;'Pet Care and Comfort, Richmond, VA 
examination. They experienced no apparent exercise intolerance, but these cats were kept indoor. Neutering under general anesthesia 
was uneventful except for the dark brown/blue discoloration of genital and other internal organs. At 10 months of age both cats had a 
moderate polycythemia (packed cell volume 54; normal 3D-45), mild reticulocytosis, and severe methemoglobinemia (Met·Hb 50 and 
52%, normal <1 %). Erythrocyte Met-Hb reductase activity, measured using ferrtcyanide as substrate, was completely deficient in both cats 
{control 9-13 IU/g Hb at 30 degrees Q. Following acetylcysteine administration for 2 days, the Met-Hb concentrations were 38 and 39%, 
respectiVely; and ascorbic add treatment lowered the Met·Hb level to 32% in one treated cat. Although the parents were not available for 
study, a male littermate to the probands had pink mucous membranes, normal Met-Hb levels (0.2%) and hematocrit (38%), but the Met­
Hb reductase activity was only 3.8 lU/g Hb (40% of controO. 
In conclusion, a severe methemoglobinemia due to a complete Met·Hb reductase deficiency was characterized in a family of domes· 
tic shorthair cats. The Intermediate Met-Hb reductase activity In a littermate suggests an autosomal recessive mode of inheritance. Affected 
cats are at increased risk because feline Hb is highly susceptible to oxidative damage. Treatment with reducing agents appears helpful in 
lowering the Met-Hb concentration. 
C
stine urolithiasis, a disorder associated with a transport 
defect for cystine and other basic amino acids, has been 
extensively studied in humans and dogs. In contrast, 
there is a paucity of Information about cystine urolithia­
sis in cats. 
Fel ine Cysti ne Urolithiasis - 1 8  Cases 
Carl Osborne,' J. Lulich,' S. Sanderson, 1 Q. Rogers,• U. Giger" 
In our series, 17 of 18 feline uroliths were composed of 100% 
cystine and 1 cystine calculi also had a small quantity of stn.Ntte 
In the outer layer. All uroliths were radiodense and were obtained 
from the lower urinary tract (calculi from 1 1  cats came from the 
'Minnesota Urolith Center, College of Veterinary Medicine, University of Minnesota, 
St. Paul, MN; 'School of Veterinary Medicine, University of California, Davis, Davis, 
CA; 3Schoo/ of Veterinary Medicine, University of Pennsylvania, Philadelphia, � 
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bladder, while samples from one cat came from the bladder and urethra, samples from one cat came from the urethra, and 5 samples 
were voided). Large radiodense bilateral renoliths subsequently developed in one cat that initially had only urocystoliths. Small nephroliths 
appeared in another cat The initial clinical signs of affected cats were characteristic of feline lower urinary tract disease (hematuria, 
dysuria, pollakiuria, and/or urethral obstruction). F€1ine cystine uroliths occurred in males (8 male castrated) and females (7 spayed; 2 
intact)with equal frequency (the gender of one cat was unknown). Mean age of cats at the time of diagnosis of cystine urolithiasis was 
3.6 years (range = 4 months to 12 . 2 years). Most cats were of the domestic short hair breed (n = 12), but 3 Siamese, one Maine Coon, 
Karat, and domestic longhair cat were also affected. The mode of inheritance has not been determined. Cystine crystalluria was a char· 
acteristic finding in urine samples collected from cats with cystine urocystoliths. Some cats also had struvlte and calcium oxalate crystal· 
Iuria. Hematuria was also a consistent finding. The urine pH of affected cats was variable, ranging from 6.0 to 8.0. Bacterial urinary tract 
infections were not observed. 
Evaluation of urine amino acid profiles of four affected cats revealed increased levels of arginine, lysine, and ornithine in addition to 
cystine. In conclusion, cystine urolithiasis may occur more commonly than previously reported, and is an important differential diagnosis 
of feline lower urinary tract disease. 
homologous animal model for Duchenne Muscular 
The Role of Basic Fibroblast Growth 
Factor and Mast Cells i n  the 
Pathogenesis of Feline Muscular 
Dystrophy 
H
ypertrophic F€1ine Muscular Dystrophy (HFMD) is a 
Dystrophy (DMD), an X·linked recessive disorder in 
humans. Contrary to DMD patients, HFMD cats do not 
develop muscle atrophy and fibrosis, but show a pronounced and 
durable muscle hypertrophy. Factors that could influence this d iffer· 
ence in regenerating capacity are growth factors and inflammatory 
cells, especially mast cells. Mast cells are able to activate growth fac· 
tor such as bFGF, an enhancer of myoblast proliferation, and may 
Gabriela S. Seiler,' Monika Welle; Frederic P. Gaschen' 
'Cfinic for Companion Animals; 'Institute of Pathology; 'Clinic for Companion 
Animals, University of Berne, Berne, Switzerland 
also play a role in the development of fibrosis. In order to investigate 
the role of bFGF and mast cells, we examined muscle biopsies of a 
HFMD-breeding colony at the University of Bern. Dystrophin-defi· 
cient cats (n=13) were compared to normal control cats (n=15) and carriers of the gene defect (n=13) at the age of 3 and 6·9 months. 
We examined the localization of bFGF in the muscle tissue by immunohistochemistry with a monoclonal antibody against human bFGF. 
With several markers of muscle regeneration like desmin, vimentin and utrophin on consecutive sections, we determined the relationship 
of bFGF to different stages of regeneration. 3 subtypes of mast cells could be distinguished by an immunohistochemical and histochem· 
ical double-labelling method for the proteases chymase and tryptase. bFGF was increased in HFMD cats, mainly in the fiber cytoplasm, 
around nuclei or satellite cells, and in areas of fiber necrosis and mononuclear infiltration. Abers containing bFGF in their cytoplasm were 
almost exclusively regenerating fibers. An accumulation of mast cells of the tryptase subtype was observed in HFMD animals. The mast 
cells were concentrated in the endomysium in areas of necrosis and early regeneration. These results indicate an important role of bFGF 
and mast cells in the pathogenesis of dystrophin deficiency, possibly through enhancement of tissue reparation, vascularization and sate!· 
lite cell proliferation. 
I 
Hereditary Thrombopathies Causing 
Bleeding in Two Domestic Shorthair Cats 
Mary Beth Callan,' Monika Griot-Wenk,' Susan Hackner,' Urs Giger' 
'Department of Clinical Studies, School of Veterinary Medicine, University of 
Pennsylvania, Philadelphia, PA; 'Veterinary Referral Associates, 
Gaithersburg, MD 
I 
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H 
ereditary platelet function disorders clinically character· 
ized by hemorrhage, prolonged bleeding time, but nor· 
mal platelet count and coagulation tests are uncommon 
in cats. A platelet &storage pool deficiency (&SPD) has 
been identified as part of the Chediak·Higashi syndrome in blue 
smoke Persian cats, but there are no previous reports of an isolated 
intrinsic platelet function defect in the cat. Here we describe inherit· 
ed thrombopathias in two young unrelated domestic shorthair cats. 
A 1.5-year-old neutered male cat was presented for evaluation of 
recurrent bilateral epistaxis, petechiation of the pinnae, and gingival 
bleeding, and a ?·month-old female cat was presented with a histo-
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ry of intermittent gingival bleeding. severe enough to result in a blood loss anemia (PCV 12%) and need for a blood transfusion. Platelet 
counts and measurements of plasma coagulant function and von Willebrand factor were normal in both cats. However, buccal mucosal 
bleeding times were prolonged in both cats (male, >8 minutes; female 6.5 minutes; normal <2 minutes). In repeated aggregation stud­
ies, platelets from both cats underwent a shape change and minimal aggregation (<5%) in response to ADP (S100 pM); there was no 
aggregation In response to low concentration of collagen (2 pgtmO and a diminished response (<40%) to a high concentration of colla­
gen (SD-100 pglml). The platelet All':ADP ratio was increased in the female cat (5.8; normal <3.6) but normal in the male cat (1 .9). Platelet 
morphology assessed by light microscopy was normal in both cats, and by electron microscopy was normal in the one cat (male) tested. 
The increase In the platelet ATP:ADP ratio in the female cat, together with impaired platelet aggregation, suggests that a platelet &SPD 
may be the cause of bleeding in this cat In light of a normal platelet All':ADP ratio in the male cat, his platelet aggregation abnormali­
ties are suggestive of a secretion/signal transduction disorder, possibly due to a defect in arachidonic acid metabolism. Hereditary throm­
bopalhias may be an important. 
R
ur related domestic shorthaired kittens were investigated 
after detection of abnormalities in their gait and difficulty 
ating and chewing. They walked with a stiff, stilted gait 
!though the apparent stiffness reduced during exercise. 
Clinical examination confirmed difficulty opening their mouths, 
skeletal muscle hypertrophy and facial and skeletal muscle 
spasms with hyperextension of the limbs and falling into lateral 
recumbency when they received a sudden fright A diagnosis of 
Myotonia congenitia was made based on the clinical signs and 
presence of spontaneous waxing and waning. high frequency dis­
charges on electromyography and the 'dive bomber' sound on 
audioprojection. Histopathologically there was moderate myofibre 
Congenital Myotonia i n  Related Cats 
Boyd R. Jones,' Fiona H. Hickford.' Margaret A. Gelhing,' Roger J. Pack, • Maurice 
R. AlleY' 
'Department of Small Animal Clinical Studies, Faculty of Veterinal}' Medicine, 
University College, Dublin, Ireland; 'Department of SmaU Animal Medicine, Comell 
University. Ithaca, NY;328 Monkstown Road, Monkslown Co., Dublin, Ire/and; 
'Institute of Animal, Veterinary & Biomedical Sciences, Massey University, 
Palmerston North, New Zealand 
hypertrophy; occasional fibres had central nuclei and rounded sarcoplasm. No histochemical abnormalities were detected. 
The findings in these cats resemble those of M. congenitia of dogs goats and humans. As all kittens were related, being from litters 
from related queens, the disease was thought to be inherited as an autosomal recessive mode of inheritance. The sire was an unknown 
stray. This is the first report of this disease in this species and the pathogenesis is thought to be associated with decreased chloride con-
ductance of muscle cell membranes as it is in those species. 
The molecular basis of human M. congenitia is established as being caused by a mutation of the gene encoding for the muscle chlo­
ride channel. Nine point mutations in exons, a base change affecting a splice consensus site, and two deletions have been described in 
the human chloride channel gene. Similar investigations are planned for the myotonic cats. 
N 
ine new-born Birman kittens were referred to the 
University of Zurich, School of Veterinary Medicine 
showing hairless of practically the entire body. At the 
breeders request, they were euthanized to determine 
the cause of disease. At necropsy, no thymus could be found; in 
Its usual location were loose connective tissue and fat on his­
tologic examination, hair follicles, sebaceous glands, and sweat 
glands were hypoplastic and reduced in number. Histologic 
examination of the normal anatomical site of the thymus 
revealed an absence of lymphocytes and Hassall's corpuscles. 
lhe lymph nodes, spleen, and Peyer's patches showed a reduc-
tion In germinal follicles and the paracortical regions contained 
few lymphocytes. 
Congenital Hypotrichosis With Thymic 
Aplasia in Bi rman Kittens 
Margret L Casal," Suzanne Arnold,' Ursula Straumann,• Christian Sigg,' Peter 
Rusch' 
'School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA; and 
'Schoo/ of \.t!terinary Medicine, University of Zurich, Zurich, Switzerland; 'School of 
Medicine, University of Zurich, ZUrich, Switzerland 
lhe pedigree revealed nine affected kittens, fwe males and four females, and nine normal kittens born in five litters to five normal par-
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ents with one common ancestor. Pedigree analysis suggested an autosomal recessive mode of inheritance. 
Hairless Birman kittens have been previously reported in Great Britain. Of the affected kittens which were not killed shortly after birth, 
none survived to 13 weeks of age. It appeared that all succumbed to Infections which are normally not lethal in immunologically Intact 
cats. Unfortunately necropsies were not performed, but this finding suggests that these kittens might � also been athymlc. 
Congenital hypotrichosis with thymic aplasia has been described in mice, rats, guinea pigs, and two calves. The clinical appearance 
and the histologic findings in these species were very similar to those found In our kittens, but further studies are needed to characterize 
the genetics of this defect and the immunologic status of the affected kittens. 
Coat Color Genes in Domestic and Wi ld 
Cats 
Eduardo Elzlrlk, Leslie A. Lyons, Naoya Yuhki, Stephen J. O'Brien 
Laboratory of Genomic Divelsity, National Gancer Institute, National Institute of 
Health, Washington, DC 
D !verse patterns of coat color variation are observed in the domestic cat, which can be related In several possible ways to color phenotypes present in other felid species. Since the beginning of this century, interesting genetic 
and evolutionary questions have been raised regarding the mecha· 
nisms underlying coat color determination and Its ewlution in the 
cat family. However the genes Involved In these traits have not yet 
been characterized In these organisms, precluding further advance in this area. The present study aims to (1) map the chromosomal loca­
tions of the major genes involved In coat color determination In the domestic cat, and assess homology with other mammalian species; 
(2) characterize at the molecular level some of these genes In the domestic cat and other felid species, and Identify mutations producing 
different phenotypes; (3) address evolutionary Issues In the Felidae pertaining to these loci. We have ascertained a large domestic cat pedi­
gree in which several coat color traits are segregating, and which will be used for the mapping approach along with the Laboratory of 
Genomic Diversity interspecific backcross pedigree and other pedigrees which may become available. We are currently characterizing at 
the molecular level the agouti locus, believed to be involved in melanistic phenotypes, through conserved primer design, PCR amplifica­
tion and direct sequencing in different felid species, characterization of clones from a domestic cat PAC genomic Ubrary, and analysis of 
mRNA obtained from skin biopsies in two different species. We are starting to investigate using similar approaches the extension locus, 
possibly also involved in melanistic phenotypes in some species, and other traits such as brown, albino (slameseAyrosinase), sliver 
(inhibitor of melanin), piebald spotting. dominant white, orange, and tabby. 
The AB Blood Group System in Wild 
FeUds 
Monlka E. Griot·Wenk, ·� Urs Giger' 
'Section of Medical Genetics, School of Veterinaly Medicine, University of 
Pennsylvsnia, Philadelphia, PA; and 'Institute of Animal Genetics, School of 
�terinaly Medicine, Ullivet$/ty of Berne, Switzerland 
8 lood type A and B erythrocyte antigens represent the only 
blood group system recognized In domestic cats (Felis catus) 
and are determined by glycolyl and acetyl neuraminic adds 
on membrane glycolipids and -proteins. The A allele Is dom­
inant over the B allele, and type AB is Inherited as a third allele. Blood 
type A is the most common type. The frequency of type A and B 
varies between geographic areas worldwide among domestic short­
hair cats and also between breeds of cats. Domestic cats possess nat-
urally-occurring alloantibodies that are responsible for neonatal iso­
erythrolysis and hemolytic transfusion reactions. In this study, we sur­
veyed the blood type of non-domesticated felids. 
A total of 131 wild cats belonging to 26 felld species (1 -16 members per spedes) from zoos and parks were studied. Based upon a 
tube hemagglutination assay established for domestic cats, 80% of felids had type-A and 18% type-B blood. Felids In the Puma group 
and African and Asian golden cats had blood type B, whereas all other species were found to have blood type A. In addition, two chee­
tahs and one bobcat had type-AB blood (2%). Red cell glycoliplds analyzed by high performance thin layer chromatography revealed a 
similar ganglioside pattern in wild cats as previously reported in domestic cats. Sera from only 8% of wild felids agglutinated type A and/or 
type B cells from domestic cats independent of the AB blood group system. Incompatible blood crossmatch reactions were only detected 
between species and more likely between members of different phylogenetic groups. 
In conclusion, wild felids display AB�rythrocyte antigens as domestic cats, and the same blood typing procedures can be applied. lhe 
majority of felid species had type A blood. The blood typing data followed the proposed phylogenetic dassification (Johnson and O'Brien 
1997). Blood incompatibility reactions were observed among different felld species. Therefore, it appears advisable to blood type and 
crossmatch wild cats to ensure blood compatibility when transfusing and breeding them. 
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C
rrier detection remains the single most effective 
means of controlling the spread of recessively 
nhertted disease. Unfortunately, many biochemical 
assays are equivocal when used to examine ani· 
mals who are carriers of inherited disease. Accurate results 
may be obtained from a vaJiety of molecular genetic tests, 
however these are often complicated, time consuming, 
expensive, and subject to contamination, requiring extensive 
quality control. Novel methods must be developed to allow 
rapid, accurate, and inexpensive carrier detection. Currently, 
Novel Molecular Methods for Carrier 
Detection of I nherited Feline Diseases 
Bruce F. Smith, VMD, PhD, Alexander SamoiloY, PhD, Polly Foureman,Phl), Nict1o111s 
Coleman, Henry J. Baker, DVM 
Scott-Ritchey Resean:h Center, College of �nary Medicine, Aubum � 
Aubum, AL 
three methods are being evaluated to detect the mutation of feline beta-galactosidase responsible for GM 1 gangliosidosis 
in the Korat and Siamese breeds. These methods include automated direct sequencing of genomic PCR fragments, which 
represents the current method employed by the laboratory for genetic diagnosis. A 5'·3' exonuclease fluorogenic release 
assay has been developed using two oligonucleotide probes, one corresponding to the sequence of each allele. The amount 
of fluorescence released is directly proportional to the number of copies of each allele, allowing specific alleles to be count· 
ed. A final assay under development utilizes genetic bit analysis, where oligonucleotides are used as primers to extend 
across the mutation site with labeled dideoxy nucleotides. DNA sequencing remains the ·gold standard' as it allows for 
directly reading the sequence of the DNA involved. However, the expense incurred, the need for multiple post PCR manip­
ulations and interpretation of the data make this the least desirable of the three techniques for clinical implementation. The 
5' fluorogenic release assay presents an attractive alternative to sequencing as it completely eliminates all post PCR pro­
cessing, and could be totally automated. However, the need for specialized equipment to perform the assay means that its 
use may be confined to large commercial or academic laboratories. Genetic bit analysis presents an appealing compromise 
between sequencing and the 5' fluorogenic release assay as it allow the sequence at one particular base to be determined 
and only requires one post PCR manipulation. Additionally, results may be determined on the bench top, without special· 
ized equipment With the advent of smaller and less expensive thermocyclers, this assay has the potential of being offered 
in  small clinical laboratories and perhaps even in the veterinarian's office. 
A
CR·based method of genetic individualization of 
omestic cats has been developed which has been 
pplied to DNA isolated from a single hair of a 
omestic cat found on a jacket left at a homicide 
scene and the blood of the suspect's pet cat Ten feline STR 
loci were selected from a subset of 400 dinucleotide 
(dC.dA)n . (dG.dl)n repeat loci isolated from genomic DNA of 
Felis catus which had been genotyped in a 70 member pedi· 
gree to generate a genetic recombination map. The STR loci 
were unlinked, demonstrated Mendelian inheritance, exhib-
Genetic Individualization of Domestic Cats 
Using Feline STR Loci for Forensic 
Applications 
Marylin Menotti-Raymond, VICtor A David, J. Claiborne Stsphens. l..eslle A Lyons, 
Stephen J. O'Brien 
Laboratory of Genomic Diversity. NCI·FCRDC, Ftederick, MD 
ited high heterozygosity and amplified with as little as one nanogram of DNA generating strong, clean electrophoretogram 
profiles. A ·match window' was empiJically established for each STR locus based on determining the measurement preci· 
sion of alleles known to be unambiguously identical by descent in the three generation pedigree. A genotype survey of two 
small population groups was performed which demonstrated that the ten loci exhibit expectations consistent with Hardy· 
weinberg equilibrium. 
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Microsatellite Analyses of Two Re­
Introduced Eurasian Lynx (Lynx lynx) 
Populations in Switzerland Using 
Heterologous Tools 
G. Obexer-Ruff,' U. Breitenmoser,' M. A. Menotti-Raymond,' C. Gaillard,' 
Ch. Breilenmoser-Wursten' 
'Institute of Animal Breeding, Veterinary Faculty, University of Berne, Berne, 
Switzerland; 2lnstitute of Veterniary Virology, Veterinary Faculty, University of 
Berne, Berne, Switzerland; 3Laboratory of Genomic Diversity, NC/-FCRDC, 
Frederick, MD; 'KORA, Muri b., Berne, Switzerland 
Lynx were extinct in most of Central and Western Europe at the end of the 19th century. In the 1970s, re-introduction programs started in the Alps and in adjacent mountain ranges of Switzerland, Slovenia, Italy, Austria, and France. In 
Switzerland, 6 lynx (4M/2f) were officially released in the Alps and 
4 animals (2M/2f) in the Jura Mountains. Due to additional dan· 
destine releases the number of founder individuals probably was 
1o-12 lynx for the Alps, and 8·10 for the Jura Mountains, respec· 
tively. All known animals originated from the wild population of the 
carpathian Mountains of Slovakia. lhe spread of the Swiss popula· 
tions has slowed down or halted in the mid·1980s. Today, the two 
populations are estimated to consist of about 50 reproducing lynx 
each. From this situation, several questions arise: (1 )  Do the two 
geographically separated lynx populations of Switzerland differ 
genetically? (2) Do the two populations have a reduced genetic vari· 
ability compared to the Slovakian source population? (3) Did the 
founder individuals all originated from the autochthonous popula· 
tion of the Carpathian Mountains? To address the first question, we 
have commenced a pilot study in order to determine the genetic diversity of the two Swiss lynx populations. lhe genetic analysis has 
been performed using microsatellites which were developped in cats. Genomic DNA was isolated from whole blood samples from the col· 
lection of the KORA. PCR amplification of 10 feline fluorescently·labelled microsatellites (FCA 026,043, 058, 080, 088, 090, 096, 126, 
132, 149) has been carried out in 10 unrelated, age and sex matched individuals per group. Furthermore, we tested 4·5 offspring of 2·3 
females per population, in order to study the mode of inheritance of the newly defined alleles. lhe allele length was determined in poly­
acrylamide gels using an ABI 373 sequencer with ABI Genescan and Genotyper software. Statistical analysis was performed using the 
GENEPOP program. All feline microsatellites amplified well in lynx. lhe observed products were inherited in a Mendelian fashion. lhe 
number of alleles detected per locus ranged from 2 to Z lhe allele size ranges differed slightly from those detected for the cat. lhe aver· 
age heterozygosity over all loci was 0.48 (0.21-0.70).When testing for Hardy-Weinberg, 9 out of 10 lod were in equilibrium. Population· 
specific alleles could only be found in a very low frequency (e.g. alleles no. 4, tea 149, 10%). A statistically significant (p<O.OOOl) differ· 
ence of the allele frequencies for the two populations could be seen for two loci (FCA 090 and 096). OUr preliminary results represent 
the first microsatellite analysis performed in the lynx and confirm the usetullness of Felis catus specific markers for this purpose. With the 
completion of the genetic map of the domestic cat, additional loci will be at our disposal to answer the questions of interest for the lynx 
species. 
Using Canine Recombinant Granulocyte 
Colony Stimulating Factor (CG-CSF) for 
Treatment of Ringworm In Cats 
A.M. Abdel-Aziz, I P.W. Gasper" 
•Faculty of Veterinary Medicine Moshtohor, Benha Branch, Zagazig University, 
Benha, Qalyoubia, Egypt; 'The Avrum Gudelsky Center for Veterinary Medicine, 
Virginia-Maryland Regional College of Veterinary Medicine, College Park, MD 
D ermatophytosls is a superfidal Infection of the kera· tinized layers of the skin, hair, and nails by zoonotic fungi. lhree dermatophytes commonly cause infection in cats: Microsporum canis, M. gypseum, and 
Trichophyton mentagrophytes and t rubum (the common human 
athletes foot fungus) Is occasionally isolated from cats. 
Microsporum canis is the most common isolate. While topical 
fungicidal agents are effective, these generally have no effect on 
spores and hyphae that may be present elsewhere on the animal. 
lhe use of systemic agents are also effective, but their side effects, 
specifically bone marrow suppression, will occasionally preclude 
their use in immune suppressed patients. 
Our question is, does canine recombinant granulocyte colony stimulating factor (cG-csf) assist in the treatment of cats with intractable 
dermatophytosis and or with dermatophytosis and immune suppression? lhe rational for this study is that a colony of Persian cats with 
miliary dermatitis and one cat with intractable dermatophytosis and immune suppression were successfully treated with G-CSF and both 
human recombinant and cG-cSF have been successfully administered to cats. We have recently initiated a study invoMng the treatment 
of pet cats that present with a variety of diseases in which the use of cG-c5F is warranted. lhe results we have obtained to date will be 
discussed. 
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